<SEC-DOCUMENT>0001193125-23-233508.txt : 20230912
<SEC-HEADER>0001193125-23-233508.hdr.sgml : 20230912
<ACCEPTANCE-DATETIME>20230912163357
ACCESSION NUMBER:		0001193125-23-233508
CONFORMED SUBMISSION TYPE:	PRE 14A
PUBLIC DOCUMENT COUNT:		7
CONFORMED PERIOD OF REPORT:	20230912
FILED AS OF DATE:		20230912
DATE AS OF CHANGE:		20230912

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ESGEN Acquisition Corp
		CENTRAL INDEX KEY:			0001865506
		STANDARD INDUSTRIAL CLASSIFICATION:	BLANK CHECKS [6770]
		IRS NUMBER:				981601409
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		PRE 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40927
		FILM NUMBER:		231250539

	BUSINESS ADDRESS:	
		STREET 1:		5956 SHERRY LANE, SUITE 1400
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75225
		BUSINESS PHONE:		214-987-6100

	MAIL ADDRESS:	
		STREET 1:		5956 SHERRY LANE, SUITE 1400
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75225
</SEC-HEADER>
<DOCUMENT>
<TYPE>PRE 14A
<SEQUENCE>1
<FILENAME>d555344dpre14a.htm
<DESCRIPTION>PRE 14A
<TEXT>
<HTML><HEAD>
<TITLE>PRE 14A</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE 14A
INFORMATION </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Proxy Statement Pursuant to Section&nbsp;14(a) of the </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Securities Exchange Act of 1934 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filed by the
Registrant&nbsp;&nbsp;&#9746; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filed by a Party other than the Registrant&nbsp;&nbsp;&#9744; </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9746;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Preliminary Proxy Statement </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B></B>&#9744;<B></B><B></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Confidential, for Use of the Commission Only (as permitted by Rule
<FONT STYLE="white-space:nowrap">14a-6(e)(2))</FONT> </B></P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Definitive Proxy Statement </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Definitive Additional Materials </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Soliciting Material Pursuant to <FONT STYLE="white-space:nowrap">Section&nbsp;240.14a-12</FONT>
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>ESGEN ACQUISITION CORPORATION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Registrant as Specified in Its Charter) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Person(s) Filing Proxy Statement, if other than the Registrant) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Payment of Filing Fee (Check all boxes that apply): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9746;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No fee required </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Fee paid previously with preliminary materials. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules
<FONT STYLE="white-space:nowrap">14a-6(i)(l)</FONT> and <FONT STYLE="white-space:nowrap">0-11.</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT COLOR="#eb0029"><B>PRELIMINARY PROXY STATEMENT&nbsp;&nbsp;-&nbsp;&nbsp;SUBJECT
</B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT COLOR="#eb0029"><B>TO COMPLETION DATED SEPTEMBER&nbsp;12, 2023</B></FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ESGEN ACQUISITION CORPORATION </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>5956 Sherry Lane, Suite 1400 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Dallas, Texas 75225 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTICE OF EXTRAORDINARY GENERAL MEETING </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TO BE HELD &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2023 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>TO THE SHAREHOLDERS OF ESGEN ACQUISITION CORPORATION: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">You are cordially invited to attend the Extraordinary General Meeting (the &#147;<B>General Meeting</B>&#148;) of <B>ESGEN ACQUISITION
CORPORATION, (the </B>&#147;<B>Company,</B>&#148;<B> </B>&#147;<B>ESGEN,</B>&#148;<B> </B>&#147;<B>we,</B>&#148;<B> </B>&#147;<B>us</B>&#148;<B> or </B>&#147;<B>our</B>&#148;) <B>to be held at
</B><B>&nbsp;&nbsp;&nbsp;&nbsp;</B><B>&nbsp;&nbsp;&nbsp;&nbsp;</B><B>&nbsp;&nbsp;&nbsp;&nbsp;</B><B>&nbsp;&nbsp;&nbsp;&nbsp;</B><B> </B>ET on
<B>&nbsp;&nbsp;&nbsp;&nbsp;</B><B>&nbsp;&nbsp;&nbsp;&nbsp;</B><B>&nbsp;&nbsp;&nbsp;&nbsp;</B><B>&nbsp;&nbsp;&nbsp;&nbsp;</B><B> 2023. The meeting will be at the offices of Kirkland</B><B></B><B>&nbsp;&amp; Ellis LLP, 609 Main Street, Houston, TX
77002 and shareholders of the Company will also be able to attend the General Meeting virtually at</B>: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The General
Meeting will be held for the purpose of considering and voting upon the following proposals and resolutions. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The Extension Proposal &#151; to consider and vote upon a proposal by the following special resolution to amend
(the &#147;<B>Extension Proposal</B>&#148;) the Company&#146;s amended and restated memorandum and articles of association (as amended from time to time to date, the &#147;<B>Existing Charter</B>&#148;) to: (i)&nbsp;extend from October&nbsp;22, 2023
(the &#147;<B>Original Extended Date</B>&#148;) to January&nbsp;22, 2024 (the &#147;<B>New Extended Date</B>&#148;),<B> </B>the date (the &#147;<B>Termination Date</B>&#148;) by which, if the Company has not consummated a merger, amalgamation, share
exchange, asset acquisition, share purchase, reorganization or similar business combination involving one or more businesses or entities, the Company must: (a)&nbsp;cease all operations except for the purpose of winding up; (b)&nbsp;as promptly as
reasonably possible but not more than ten business days thereafter, redeem the shares sold in the Company&#146;s initial public offering (the &#147;<B>Public Shares</B>&#148;) (in a redemption that will completely extinguish the rights of the owners
of the Public Shares as shareholders (including the right to receive further liquidation distributions, if any)) at a <FONT STYLE="white-space:nowrap">per-share</FONT> price, payable in cash, equal to (1)&nbsp;the aggregate amount then on deposit in
the trust account located in the United States with Continental Stock Transfer&nbsp;&amp; Trust Company acting as trustee (&#147;<B>Trust Account</B>&#148;), including interest earned on the funds held in the Trust Account and not previously
released to the Company to pay its income taxes, if any, less up to $100,000 of interest to pay winding up and dissolution expenses (net of any taxes payable), divided by (2)&nbsp;the number of the then-outstanding Public Shares; and (c)&nbsp;as
promptly as reasonably possible following such redemption, subject to the approval of the Company&#146;s remaining shareholders and the Company&#146;s board of directors (the &#147;<B>Board</B>&#148;), liquidate and dissolve, subject in the case of
clauses (b)&nbsp;and (c) to the Company&#146;s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law, and (ii)&nbsp;in the event that the Company has not consummated an initial business
combination by the New Extended Date, to allow the Company, by resolution of the board of directors of the Company and, without any approval of the Company&#146;s shareholders, upon five days&#146; advance notice prior to the New Extended Date, to
extend the Termination Date up to six times (with each such extension being upon five days&#146; advance notice), each by one additional month (for a total of up to six additional months to complete a business combination) (each, an
&#147;<B>Additional Extension Date</B>&#148;), provided that the Company&#146;s sponsor, ESGEN LLC (the &#147;<B>Sponsor</B>&#148;) or the Sponsor&#146;s affiliates or permitted designees (the &#147;<B>Lenders</B>&#148; and each a
&#147;<B>Lender</B>&#148;) will deposit into the Trust Account for each Additional Extension Date the lesser of (a)&nbsp;US$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; or (b)
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; for each Public Share that is then-outstanding, in exchange for one or more <FONT STYLE="white-space:nowrap">non-interest</FONT> bearing, unsecured
promissory notes </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
issued by the Company to the Lender. If the Company completes its initial business combination, it will, at the option of the Lender, repay the amounts loaned under the promissory note(s) or
convert a portion or all of the amounts loaned under such promissory note(s) into warrants at a price of $1.00 per warrant, which warrants will be identical to the private placement warrants, each exercisable to purchase one Class&nbsp;A ordinary
share, par value $0.0001 (the &#147;<B>Class</B><B></B><B>&nbsp;A ordinary share</B>&#148;) at $11.50 per share, subject to adjustment, at a price of $1.00 per warrant issued to the Sponsor at the time of the Company&#146;s initial public offering
(&#147;<B>IPO</B>&#148;).<B> </B>If the Company does not complete a business combination by the deadline to consummate an initial business combination, such promissory notes will be repaid only from funds held outside of the Trust Account:
</P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">&#147;RESOLVED, as a special resolution, that the proposed payment by the Company from the Company&#146;s working
capital account into the Trust Account of the lesser of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; or
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; for each Public Share that is outstanding following the exercise of redemption rights in connection with the Extension Proposal be approved and that
the Amended and Restated Memorandum and Articles of Association of the Company be amended by the deletion of the existing Article 165 in its entirety and the insertion of the following language in its place: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">165 (a) In the event that either the Company does not consummate a Business Combination by twenty seven months after the closing of the IPO,
subject to any extension in accordance with Article 165 (c), the Company shall: (i)&nbsp;cease all operations except for the purpose of winding up; (ii)&nbsp;as promptly as reasonably possible but not more than ten business days thereafter, redeem
the Public Shares, at a <FONT STYLE="white-space:nowrap">per-Share</FONT> price, payable in cash, equal to the aggregate amount then on deposit in the Trust Fund, including interest earned on the Trust Fund and not previously released to the Company
to pay income taxes, if any (less up to $100,000 of interest to pay winding up and dissolution expenses), divided by the number of Public Shares then in issue, which redemption will completely extinguish public Members&#146; rights as Members
(including the right to receive further liquidation distributions, if any); and (iii)&nbsp;as promptly as reasonably possible following such redemption, subject to the approval of the Company&#146;s remaining Members and the Directors, liquidate and
dissolve, subject in the case of <FONT STYLE="white-space:nowrap">sub-articles</FONT> (ii)&nbsp;and (iii), to its obligations under Cayman Islands law to provide for claims of creditors and in all cases subject to the other requirements of
applicable law. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">165 (b) If any amendment is made to Article 165(a) or 165(c) that would modify the substance or timing of the
Company&#146;s obligation to provide holders of the Class&nbsp;A Shares the right to have their shares redeemed in connection with the Business Combination or to redeem 100% of the Public Shares if the Company does not complete its initial Business
Combination by January&nbsp;22, 2024 (the &#147;<B>Initial Business Combination Date</B>&#148;) or any subsequent Additional Extension Date (as defined below) or with respect to any other provision relating to the rights of holders of the
Class&nbsp;A Shares, each holder of Public Shares shall be provided with the opportunity to redeem their Public Shares upon the approval of any such amendment at a <FONT STYLE="white-space:nowrap">per-Share</FONT> price, payable in cash, equal to
the aggregate amount then on deposit in the Trust Fund, including interest earned on the Trust Fund and not previously released to the Company to pay its income taxes, if any (less up to $100,000 of interest to pay winding up and dissolution
expenses), divided by the number of Public Shares then in issue. Notwithstanding the foregoing, the Company shall not redeem Public Shares in connection with such amendment that would cause the Company&#146;s net tangible assets to be less than
US$5,000,001 (upon consummation of the Business Combination and after payment of underwriter fees and commissions) following such redemptions. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">165 (c) Notwithstanding this Article or any other provision of the Articles, in the event that the Company has not consummated an initial
Business Combination by the Initial Business Combination Date, the Company may, if requested by the Sponsor, without any approval of the Members, by resolution of the board of Directors and upon five days&#146; advance notice prior to the Initial
Business Combination Date, extend the deadline date of the initial Business Combination up to six times (with each such extension being upon five days&#146; advance notice) (each, an &#147;<B>Additional Extension Date</B>&#148;), each by one
additional month (for a total of up to six additional months to complete a Business Combination), provided that the Sponsor (or its affiliates or permitted designees) (the &#147;<B>Lender</B>&#148;) will deposit into the Trust Account: the lesser of
(a)&nbsp;US$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;or (b) $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; for each Public Share that is
then-outstanding, in exchange for one or more <FONT STYLE="white-space:nowrap">non-interest</FONT> bearing, unsecured promissory notes issued by the Company to the Lender. If </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">
the Company completes its initial Business Combination, it will, at the option of the Lender, repay the amounts loaned under the promissory note or convert a portion or all of the amounts loaned
under such promissory note(s) into warrants at a price of $1.00 per warrant, which warrants will be identical to the private placement warrants issued to the Sponsor at the time of the IPO. If the Company does not complete a Business Combination by
the deadline to consummate an initial Business Combination, such promissory notes will be repaid only from funds held outside of the Trust Account.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Such amendment is referred to herein as the &#147;<B>Extension Amendment</B>&#148;. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The Adjournment Proposal &#151; to consider and vote upon a proposal by the following ordinary resolution to
approve the adjournment of the General Meeting by the chairman (the &#147;<B>Chairman</B>&#148;) thereof to a later date, if necessary, under certain circumstances, to solicit additional proxies for the purpose of approving the Extension Proposal,
to amend the Extension Proposal, or to allow reasonable additional time for the filing or mailing of any supplemental or amended disclosure that the Company has determined in good faith after consultation with outside legal counsel is required under
applicable law and for such supplemental or amended disclosure to be disseminated and reviewed by the Company&#146;s shareholders prior to the General Meeting; provided that the General Meeting is reconvened as promptly as practical thereafter. The
Adjournment Proposal will only be presented at the General Meeting if there are not sufficient tabulated votes to approve the Extension Proposal: </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">&#147;RESOLVED, as an ordinary resolution, that the adjournment of the extraordinary general meeting to a time and place to be confirmed by the
Chairman of the extraordinary general meeting be ratified, approved and confirmed in all respects.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We do not believe that our
anticipated principal activities will subject us to the Investment Company Act of 1940 (the &#147;<B>Investment Company Act</B>&#148;). To this end, the proceeds held in the Trust Account may only be invested in United States &#147;government
securities&#148; within the meaning of Section&nbsp;2(a)(16) of the Investment Company Act having a maturity of 185&nbsp;days or less or in money market funds meeting certain conditions
<FONT STYLE="white-space:nowrap">under&nbsp;Rule&nbsp;2a-7&nbsp;promulgated</FONT> under the Investment Company Act which invest only in direct U.S. government treasury obligations. Pursuant to the trust agreement, the trustee is not permitted to
invest in other securities or assets. By restricting the investment of the proceeds to these instruments, and by having a business plan targeted at acquiring and growing businesses for the long term (rather than on buying and selling businesses in
the manner of a merchant bank or private equity fund), we intend to avoid being deemed an &#147;investment company&#148; within the meaning of the Investment Company Act. Our initial public offering was not intended for persons who are seeking a
return on investments in government securities or investment securities. The Trust Account is intended as a holding place for funds pending the earliest to occur of either: (i)&nbsp;the completion of our initial business combination; (ii)&nbsp;the
redemption of any public shares properly tendered in connection with a shareholder vote to amend our amended and restated memorandum and articles of association (A)&nbsp;to modify the substance or timing of our obligation to provide holders of our
Class&nbsp;A ordinary shares the right to have their shares redeemed in connection with our initial business combination or to redeem 100% of our public shares if we do not complete our initial business combination within 27 months from the closing
of our initial public offering (or up to 33&nbsp;months, if we extend the time to complete a business combination) or (B)&nbsp;with respect to any other provision relating to the rights of holders of our Class&nbsp;A ordinary shares; or
(iii)&nbsp;absent our completing an initial business combination within 27 months from the closing of our initial public offering (or up to 33 months, if we extend the time to complete a business combination), our return of the funds held in the
Trust Account to our public shareholders as part of our redemption of the public shares. If we do not invest the proceeds as discussed above, we may be deemed to be subject to the Investment Company Act. If we were deemed to be subject to the
Investment Company Act, compliance with these additional regulatory burdens would require additional expenses for which we have not allotted funds and may hinder our ability to complete a business combination. If we have not consummated our initial
business combination within the required time period, our public shareholders may receive only approximately $10.20 per public share, or less in certain circumstances, on the liquidation of our trust account and our warrants will expire worthless.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the Extension Proposal is approved and the Extension Amendment becomes effective, within five business days of the date of the General
Meeting, the Company will make a payment from the Company&#146;s working capital </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
account into the Trust Account of the lesser of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; or
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; for each Public Share that is outstanding following the exercise of redemption rights in connection with the Extension Proposal. In addition, if the
Extension Proposal is approved and the Extension Amendment becomes effective, in the event that the Company has not consummated an initial business combination by the New Extended Date, by resolution of the Board and, without any approval of the
Company&#146;s shareholders, the Company may, upon five days&#146; advance notice prior to the New Extended Date, to extend the Termination Date up to six times (with each such extension being upon five days&#146; advance notice), each by one
additional month (for a total of up to six additional months to complete a business combination) (each, an &#147;<B>Additional Extension Date</B>&#148;), provided that a Lender will deposit into the Trust Account for each Additional Extension Date
the lesser of (a)&nbsp;US$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; or (b) $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; for each Public Share
that is then-outstanding. If the Company completes its initial business combination, it will, at the option of the Lender, repay the amounts loaned under the promissory note(s) or convert a portion or all of the amounts loaned under such promissory
note(s) into warrants at a price of $1.00 per warrant, which warrants will be identical to the private placement warrants, each exercisable to purchase one Class&nbsp;A ordinary share at $11.50 per share, subject to adjustment, at a price of $1.00
per warrant issued to the Sponsor at the time of the Company&#146;s IPO. If the Company does not complete a business combination by the deadline to consummate an initial business combination, such promissory notes will be repaid only from funds held
outside of the Trust Account. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Your attention is directed to the Proxy Statement accompanying this Notice for a more complete statement of
matters to be considered at the General Meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board has fixed the close of business on September&nbsp;13, 2023 as the date for
determining the Company&#146;s shareholders entitled to receive notice of and to vote at the General Meeting and any adjournment thereof (the &#147;<B>Record Date</B>&#148;). Only holders of record of the Company&#146;s Class&nbsp;A ordinary shares
and Class&nbsp;B ordinary shares, par value $0.0001 (the &#147;<B>Class</B><B></B><B>&nbsp;B ordinary shares</B>&#148; and collectively with the Class&nbsp;A ordinary shares, the &#147;<B>Ordinary Shares</B>&#148;) on that date are entitled to have
their votes counted at the General Meeting or any adjournment thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">After careful consideration of all relevant factors, the Board
recommends that you vote or give instructions to vote (i) &#147;FOR&#148; the Extension Proposal; and (ii) &#147;FOR&#148; the Adjournment Proposal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Enclosed is the proxy statement containing detailed information concerning the Extension Proposal, the Adjournment Proposal and the General
Meeting. Whether or not you plan to virtually attend the General Meeting, we urge you to read this material carefully and vote your shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">I look forward to seeing you at the meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">By Order of the Board of Directors, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Andrea Bernatova <I> </I></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman"><I>Chief Executive Officer and Director</I> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2023 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Your vote is important. Please sign, date and return your proxy card as soon as possible but in any event so as to be received by Morrow
Sodali LLC prior to the commencement of the General Meeting to make sure that your shares are represented at the General Meeting. If you are a shareholder of record, you may also cast your vote in person (including virtually) at the General Meeting.
If your shares are held in an account at a brokerage firm or bank, you must instruct your broker or bank how to vote your shares, or you may cast your vote in person (including virtually) at the General Meeting by obtaining a proxy from your
brokerage firm or bank. Your failure to vote or instruct your broker or bank how to vote will have no effect on the outcome of the proposals. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Important Notice Regarding the Availability of Proxy Materials for the Extraordinary General Meeting to be held on
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2023: This notice of meeting, the accompany proxy statement, proxy card and annual report are available at
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;. </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ESGEN ACQUISITION CORPORATION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>5956 Sherry Lane, Suite 1400 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Dallas, Texas 75225 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROXY STATEMENT </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">ESGEN
ACQUISITION CORPORATION, (the &#147;<B>Company</B>,&#148; &#147;<B>ESGEN</B>,&#148; &#147;<B>we,</B>&#148; &#147;<B>us</B>&#148; or &#147;<B>our</B>&#148;), a Cayman Islands exempted company, is providing this proxy statement in connection with the
solicitation by the Company&#146;s Board of Directors (the &#147;<B>Board</B>&#148;) of proxies to be voted at the General Meeting to be held at &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ET on
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2023. The meeting will be at the offices of Kirkland&nbsp;&amp; Ellis LLP, 609 Main Street, Houston, TX 77002 and shareholders of the Company will also
be able to attend the General Meeting virtually at: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The General
Meeting will be held for the sole purpose of considering and voting upon: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The Extension Proposal &#151; to consider and vote upon a proposal by the following special resolution to amend
(the &#147;<B>Extension Proposal</B>&#148;) the Company&#146;s amended and restated memorandum and articles of association (together, the &#147;<B>Existing Charter</B>&#148;) to: (i)&nbsp;extend from October&nbsp;22, 2024 (the &#147;<B>Original
Extended Date</B>&#148;) to January&nbsp;22, 2024 (the &#147;<B>New Extended Date</B>&#148;),<B> </B>the date (the &#147;<B>Termination Date</B>&#148;) by which, if the Company has not consummated a merger, amalgamation, share exchange, asset
acquisition, share purchase, reorganization or similar business combination involving one or more businesses or entities, the Company must: (a)&nbsp;cease all operations except for the purpose of winding up; (b)&nbsp;as promptly as reasonably
possible but not more than ten business days thereafter, redeem the shares sold in the Company&#146;s initial public offering (the &#147;<B>Public Shares</B>&#148;) (in a redemption that will completely extinguish the rights of the owners of the
Public Shares as shareholders (including the right to receive further liquidation distributions, if any)) at a <FONT STYLE="white-space:nowrap">per-share</FONT> price, payable in cash, equal to (1)&nbsp;the aggregate amount then on deposit in the
trust account located in the United States with Continental Stock Transfer&nbsp;&amp; Trust Company acting as trustee (&#147;<B>Trust Account</B>&#148;), including interest earned on the funds held in the Trust Account and not previously released to
the Company to pay its income taxes, if any, less up to $100,000 of interest to pay winding up and dissolution expenses (net of any taxes payable), divided by (2)&nbsp;the number of the then-outstanding Public Shares; and (c)&nbsp;as promptly as
reasonably possible following such redemption, subject to the approval of the Company&#146;s remaining shareholders and the Board, liquidate and dissolve, subject in the case of clauses (b)&nbsp;and (c) to the Company&#146;s obligations under Cayman
Islands law to provide for claims of creditors and the requirements of other applicable law, and (ii)&nbsp;in the event that the Company has not consummated an initial business combination by the New Extended Date, to allow the Company, by
resolution of the Board and, without any approval of the Company&#146;s shareholders, upon five days&#146; advance notice prior to the New Extended Date to extend the Termination Date up to six times (with each such extension being upon five
days&#146; advance notice), each by one additional month (for a total of up to six additional months to complete a business combination) (each, an &#147;<B>Additional Extension Date</B>&#148;), provided that the Company&#146;s sponsor, ESGEN LLC
(the &#147;<B>Sponsor</B>&#148;) or the Sponsor&#146;s affiliates or permitted designees (the &#147;<B>Lenders</B>&#148; and each a &#147;<B>Lender</B>&#148;) will deposit into the Trust Account for each Additional Extension Date the lesser of
(a)&nbsp;US$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; or (b) $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; for each Public Share that is
then-outstanding, in exchange for one or more <FONT STYLE="white-space:nowrap">non-interest</FONT> bearing, unsecured promissory notes issued by the Company to the Lender. If the Company completes its initial business combination, it will, at the
option of the Lender, repay the amounts loaned under the promissory note(s) or convert a portion or all of the amounts loaned under such promissory note(s) into warrants at a price of $1.00 per warrant, which warrants will be identical to the
private placement warrants, each exercisable to purchase one Class&nbsp;A ordinary share, par value $0.0001 (the &#147;<B>Class</B><B></B><B>&nbsp;A ordinary share</B>&#148;) at $11.50 per share, subject to adjustment, at a price of $1.00 per
warrant issued to the Sponsor at the time of the Company&#146;s initial public offering (&#147;<B>IPO</B>&#148;).<B> </B>If the Company does not complete a business combination </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
by the deadline to consummate an initial business combination, such promissory notes will be repaid only from funds held outside of the Trust Account; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The Adjournment Proposal &#151; to consider and vote upon a proposal (the &#147;<B>Adjournment
Proposal</B>&#148;) by ordinary resolution to approve the adjournment of the General Meeting by the chairman (the &#147;<B>Chairman</B>&#148;) thereof to a later date, if necessary, under certain circumstances, to solicit additional proxies for the
purpose of approving the Extension Proposal, to amend the Extension Proposal, or to allow reasonable additional time for the filing or mailing of any supplemental or amended disclosure that the Company has determined in good faith after consultation
with outside legal counsel is required under applicable law and for such supplemental or amended disclosure to be disseminated and reviewed by the Company&#146;s shareholders (&#147;<B>Shareholders</B>&#148;) prior to the General Meeting; provided
that the General Meeting is reconvened as promptly as practical thereafter. The Adjournment Proposal will only be presented at the General Meeting if there are not sufficient tabulated votes to approve the Extension Proposal. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The proposed amendment to the Existing Charter pursuant to the Extension Proposal is referred to herein as the &#147;<B>Extension
Amendment</B>&#148;. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The purpose of the Extension Proposal is to allow the Company additional time to complete an initial business
combination. The Company&#146;s Existing Charter provides that the Company has until October&nbsp;22, 2023 to complete an initial business combination. Accordingly, the Board has determined that it is in the best interests of the Company to extend
the date that the Company has to consummate an initial business combination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the Extension Proposal is approved, the Company would
have up to an additional nine months after the Original Extended Date to consummate an initial business combination, until July&nbsp;22, 2024, which is a total of up to 33 months from the consummation of the Company&#146;s IPO to complete an initial
business combination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the Extension Proposal is approved and the Extension Amendment becomes effective, within five business days of
the date of the General Meeting, the Company will make a payment from the Company&#146;s working capital account into the Trust Account of the lesser of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; or $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; for each Public Share that is outstanding
following the exercise of redemption rights in connection with the Extension Proposal. In addition, if the Extension Proposal is approved and the Extension Amendment becomes effective, in the event that the Company has not consummated an initial
business combination by the New Extended Date, by resolution of the Board and, without any approval of the Company&#146;s shareholders, the Company may, upon five days&#146; advance notice prior to the New Extended Date extend the Termination Date
up to six times (with each such extension being upon five days&#146; advance notice), each by one additional month (for a total of up to six additional months to complete a business combination), provided that a Lender will deposit into the Trust
Account for each Additional Extension Date the lesser of (a)&nbsp;US$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; or (b)
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; for each Public Share that is then-outstanding, in exchange for one or more <FONT STYLE="white-space:nowrap">non-interest</FONT> bearing, unsecured
promissory notes issued by the Company to the Lender. If the Company completes its initial business combination, it will, at the option of the Lender, repay the amounts loaned under the promissory note(s) or convert a portion or all of the amounts
loaned under such promissory note(s) into warrants at a price of $1.00 per warrant, which warrants will be identical to the private placement warrants, each exercisable to purchase one Class&nbsp;A ordinary share at $11.50 per share, subject to
adjustment, at a price of $1.00 per warrant issued to the Sponsor at the time of the Company&#146;s IPO. If the Company does not complete a business combination by the deadline to consummate an initial business combination, such promissory notes
will be repaid only from funds held outside of the Trust Account. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board has fixed the close of business on September&nbsp;13, 2023 as
the date for determining the Company&#146;s shareholders entitled to receive notice of and to vote at the General Meeting and any adjournment thereof (the &#147;<B>Record Date</B>&#148;). Only holders of record of the Company&#146;s Class&nbsp;A
ordinary shares and Class&nbsp;B ordinary shares, par value $0.0001 (the &#147;<B>Class</B><B></B><B>&nbsp;B ordinary shares</B>&#148; and collectively with the Class&nbsp;A ordinary shares, the &#147;<B>Ordinary Shares</B>&#148;) on the Record Date
are entitled to have their votes counted at the General Meeting or any adjournment thereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This proxy statement contains important information about the General Meeting, the Extension
Proposal, and the Adjournment Proposal. Please read it carefully and vote your shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This proxy statement is dated
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2023 and, together with the proxy card, is first being mailed to shareholders on or about that date. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>QUESTIONS AND ANSWERS ABOUT THE GENERAL MEETING </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">These Questions and Answers are only summaries of the matters they discuss. They do not contain all of the information that may be important
to you. You should carefully read the entire document, including the annexes to this proxy statement. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What is being voted on? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">You are being asked to consider and vote upon (A)&nbsp;a proposal by special resolution to amend the
Company&#146;s Existing Charter (such amendment, the &#147;<B>Extension Amendment</B>&#148;) to: (i)&nbsp;extend from October&nbsp;22, 2023 to January&nbsp;22, 2024, the date (the &#147;<B>Termination Date</B>&#148;) by which, if the Company has not
consummated a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination involving one or more businesses or entities, the Company must: (a)&nbsp;cease all operations except for the
purpose of winding up; (b)&nbsp;as promptly as reasonably possible but not more than ten business days thereafter, redeem the shares sold in the Company&#146;s initial public offering (the &#147;<B>Public Shares</B>&#148;) (in a redemption that will
completely extinguish the rights of the owners of the Public Shares as shareholders (including the right to receive further liquidation distributions, if any)) at a <FONT STYLE="white-space:nowrap">per-share</FONT> price, payable in cash, equal to
(1)&nbsp;the aggregate amount then on deposit in the trust account located in the United States with Continental Stock Transfer&nbsp;&amp; Trust Company acting as trustee (&#147;<B>Trust Account</B>&#148;), including interest earned on the funds
held in the Trust Account and not previously released to the Company to pay its income taxes, if any, less up to $100,000 of interest to pay winding up and dissolution expenses (net of any taxes payable), divided by (2)&nbsp;the number of the
then-outstanding Public Shares; and (c)&nbsp;as promptly as reasonably possible following such redemption, subject to the approval of the Company&#146;s remaining shareholders and the Board, liquidate and dissolve, subject in the case of clauses
(b)&nbsp;and (c) to the Company&#146;s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law, and (ii)&nbsp;in the event that the Company has not consummated an initial business
combination by the New Extended Date, to allow the Company, by resolution of the Board and, without any approval of the Company&#146;s shareholders, upon five days&#146; advance notice prior to the New Extended Date to extend the Termination Date up
to six times (with each such extension being upon five days&#146; advance notice), each by one additional month (for a total of up to six additional months to complete a business combination) (each, an &#147;<B>Additional Extension Date</B>&#148;),
provided that the Company&#146;s sponsor, ESGEN LLC (the &#147;<B>Sponsor</B>&#148;) or the Sponsor&#146;s affiliates or permitted designees (the &#147;<B>Lenders</B>&#148; and each a &#147;<B>Lender</B>&#148;) will deposit into the Trust Account
for each Additional Extension Date the lesser of (a)&nbsp;US$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; or
(b)&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; for each Public Share that is then-outstanding, in exchange for one or more <FONT STYLE="white-space:nowrap">non-interest</FONT> bearing,
unsecured promissory notes issued by the Company to the Lender; and (B)&nbsp;a proposal to adjourn the General Meeting if necessary. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Why is the Company proposing the Extension Proposal? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Company is a blank check company incorporated on April&nbsp;19, 2021 as a Cayman Islands exempted company.
We were incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses, which we refer to as our initial business
combination. On October&nbsp;22, 2021, the Company consummated its IPO of 27,600,000 units (the &#147;<B>Units</B>&#148;) at $10.00 per Unit (which included the full exercise of the underwriters&#146; over-allotment option), and the sale of
14,040,000 warrants (the &#147;<B>Private Placement Warrants</B>&#148;) each exercisable to purchase one Class&nbsp;A ordinary share, par value $0.0001 (the &#147;<B>Class</B><B></B><B>&nbsp;A ordinary share</B>&#148;) at $11.50 per share, subject
to adjustment, at a price of $1.00 per Private Placement Warrant in a private placement (the &#147;<B>Private Placement</B>&#148;) to the Sponsor and Salient Capital Advisors, LLC, (&#147;<B>Salient</B>&#148;) acting in its capacity as investment
advisor on behalf of one or more client accounts (&#147;<B>Salient Client Accounts</B>&#148;) that closed simultaneously with the Company&#146;s IPO. Following the consummation of the Company&#146;s IPO, a total of $281,520,000 of the net proceeds
from the Company&#146;s IPO and the Private Placement were deposited in the Trust Account established for the benefit of the persons holding Public Shares <B>(</B>&#147;<B>Public Shareholders</B>&#148;). </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Our Existing Charter provides for the return of the Company&#146;s IPO proceeds held in the
Trust Account to the holders of Public Shares if there is no qualifying business combination(s) consummated on or before October&nbsp;22, 2023. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On January&nbsp;18, 2023, at an extraordinary general meeting of our shareholders, our shareholders approved an amendment to the amended and
restated memorandum and articles of association of the Company then in effect to extend the date by which we must consummate a Business Combination from January&nbsp;22, 2023 to October&nbsp;22, 2023 (the &#147;<B>First Extension</B>&#148;). In
connection with the First Extension, shareholders holding 24,703,445 Class&nbsp;A ordinary shares of ESGEN exercised their right to redeem their shares for cash at a redemption price of approximately $10.35 per share, for an aggregate redemption
amount of approximately $254,198,449. As of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2023, there was
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; in the Trust Account. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On April&nbsp;19,
2023, ESGEN, ESGEN OpCo, LLC, a Delaware limited liability company and wholly-owned subsidiary of ESGEN (&#147;<B>OpCo</B>&#148;), Sunergy Renewables, LLC, a Nevada limited liability company (&#147;<B>Sunergy</B>&#148;), the Sunergy equityholders
set forth on the signature pages thereto (collectively, &#147;<B>Sellers</B>&#148; and each, a &#147;<B>Seller</B>&#148;, and collectively with Sunergy, the &#147;<B>Sunergy Parties</B>&#148;), for limited purposes, Sponsor, and for limited
purposes, Timothy Bridgewater, an individual, in his capacity as the Sellers Representative, entered into a Business Combination Agreement (as it may be amended, supplemented or otherwise modified from time to time, the &#147;<B>Business Combination
Agreement</B>&#148; and the proposed transactions thereunder, the &#147;<B>Business Combination</B>&#148;). For more information about the Business Combination Agreement, see our Current Report on
<FONT STYLE="white-space:nowrap">Form&nbsp;8-K&nbsp;filed</FONT> with the Securities and Exchange Commission (the&nbsp;&#147;<B>SEC</B>&#148;) on April&nbsp;20, 2023. Furthermore, we intend to file a registration statement that includes a
preliminary proxy statement/prospectus and, after the registration statement is declared effective, we will mail a definitive proxy statement/prospectus to our shareholders relating to the Business Combination. The registration statement, including
the proxy statement/prospectus contained therein, when declared effective by the SEC, will contain important information about the proposed Business Combination and the other matters to be voted upon at a meeting of our shareholders to be held to
approve the proposed Business Combination (and related matters). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company believes that given its expenditure of time, effort, and
money searching for potential business combination opportunities, including with respect to the negotiation of the Business Combination Agreement and the ongoing efforts toward the closing of the Business Combination, the Public Shareholders of the
Company should be given an opportunity to consider and vote on an initial business combination. We do not believe that we will have sufficient time to consummate the proposed Business Combination prior to October&nbsp;22, 2023. Therefore, we are
seeking approval of the Extension Proposal. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Board believes that it is in the best interests of the Company to continue the
Company&#146;s existence in order to allow the Company more time to complete the proposed Business Combination. Accordingly, the Board is proposing the Extension Proposal to extend the Company&#146;s corporate existence. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>YOU ARE NOT BEING ASKED TO VOTE ON AN INITIAL BUSINESS COMBINATION AT THIS TIME. IF THE EXTENSION PROPOSAL IS APPROVED AND THE EXTENSION
AMENDMENT BECOMES EFFECTIVE AND YOU DO NOT ELECT TO REDEEM YOUR PUBLIC SHARES NOW, YOU WILL RETAIN THE RIGHT TO VOTE ON AN INITIAL BUSINESS COMBINATION WHEN IT IS SUBMITTED TO SHAREHOLDERS AND THE RIGHT TO REDEEM YOUR PUBLIC SHARES FOR A PRO RATA
PORTION OF THE TRUST ACCOUNT IN THE EVENT AN INITIAL BUSINESS COMBINATION IS APPROVED AND COMPLETED OR THE COMPANY HAS NOT CONSUMMATED AN INITIAL BUSINESS COMBINATION BY THE NEW EXTENDED DATE (OR THE ADDITIONAL EXTENSION DATE, IF APPLICABLE).
</B></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Why should I vote for the Extension Proposal? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Board believes shareholders will benefit from the Company consummating an initial business combination and
is proposing the Extension Proposal to extend the date by which the Company has to </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
complete an initial business combination and would allow you as a shareholder the benefit of voting for an initial business combination and remaining a shareholder in the post-business
combination company, if you desire. </TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Accordingly, we believe that the Extension Proposal is consistent with the spirit in
which the Company offered its securities to the public in the Company&#146;s IPO. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">You will have redemption rights in connection with the
Extension Proposal; however, you will not have any redemption rights in connection with the Company&#146;s electing to extend on a monthly basis, up to six times, after the New Extended Date until the Additional Extension Date. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>May I redeem my Public Shares in connection with the vote on the Extension Proposal?
</B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Yes. Under our Existing Charter, the submission of a matter to amend our Existing Charter in this respect
entitles holders of Public Shares to redeem their shares for their pro rata portion of the funds held in the Trust Account established at the time of the Company&#146;s IPO. Holders of Public Shares do not need to vote against the Extension Proposal
or be a holder of record on the Record Date to exercise their redemption rights. </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">If the Extension Proposal is approved,
with respect to holders&#146; right to redeem, the Company will (i)&nbsp;remove from the Trust Account an amount (the &#147;<B>Withdrawal Amount</B>&#148;) equal to the pro rata portion of funds available in the Trust Account relating to any Public
Shares redeemed by holders in connection with the Extension Proposal, if any, and (ii)&nbsp;deliver to the holders of such redeemed Public Shares their pro rata portion of the Withdrawal Amount. The remainder of such funds shall remain in the Trust
Account and be available for use by the Company to complete an initial business combination on or before the New Extended Date or the Additional Extension Date, if applicable. Holders of Public Shares who do not redeem their Public Shares now will
retain their redemption rights and their ability to vote on an initial business combination. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Why is the Company proposing the Adjournment Proposal? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To allow the Company more time to solicit additional proxies in favor of the Extension Proposal, in the event
the Company does not receive the requisite shareholder vote to approve the Extension Proposal. The Adjournment Proposal may be put to the General Meeting as the first resolution to be voted on. </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>How do the Company&#146;s executive officers, directors and affiliates intend to vote their shares?
</B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">All of the Company&#146;s directors, executive officers and their respective affiliates, as well as the Sponsor
and the Salient Client Accounts, are expected to vote any Ordinary Shares over which they have voting control (including any Public Shares owned by them) in favor of the Extension Proposal and the Adjournment Proposal. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Our Sponsor, executive officers, directors and the Salient Client Accounts are not entitled to redeem such shares in connection with the
Extension Proposal. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">On the Record Date, they held
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ordinary Shares representing approximately &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;% of the
Company&#146;s issued and outstanding Ordinary Shares. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The Company&#146;s Sponsor, the Salient Client Accounts, directors and executive
officers beneficially owned &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Public Shares in the aggregate as of the Record Date and may choose to purchase additional Public Shares in the open market
and/or through negotiated private transactions after the date of this proxy statement. In the event that such purchases do occur, the purchasers may seek to purchase shares from shareholders who would otherwise have voted against the Extension
Proposal and/or elected to redeem their shares. Any Public Shares so purchased will be voted in favor of the Extension Proposal. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What vote is required to adopt the proposals? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Extension Proposal. </B>The Extension Proposal must be approved by a special resolution as a matter of
Cayman Islands law, being the affirmative vote of at least a <FONT STYLE="white-space:nowrap">two-thirds</FONT> majority of the votes cast by the holders of the Ordinary Shares who are present in person (including virtually) or represented by proxy
and entitled to vote at the General Meeting. </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Adjournment Proposal. </B>The Adjournment Proposal must be approved by
an ordinary resolution as a matter of Cayman Islands law, being the affirmative vote of a majority of the votes cast by the holders of the Ordinary Shares who are present in person (including virtually) or represented by proxy and entitled to vote
at the General Meeting. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What if I do not want to approve the Extension Proposal or the Adjournment Proposal?
</B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If you do not want to approve the Extension Proposal or the Adjournment Proposal, you may &#147;ABSTAIN&#148;,
not vote or vote &#147;AGAINST&#148; such proposal. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Will you seek any further extensions to liquidate the Trust Account? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Other than the extensions until the New Extended Date, or the Additional Extension Date, if applicable, as of
the date of this proxy statement, we do not anticipate seeking any further extension to consummate a business combination, although we may determine to do so in the future, if necessary. </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What happens if the Extension Proposal is not approved? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If based on the tabulated vote there are insufficient votes to approve the Extension Proposal, the Company may
put the Adjournment Proposal to a vote as the first resolution in order to seek additional time to obtain sufficient votes in support of the Extension Amendment. If the Extension Proposal is not approved at the General Meeting, we expect to take all
necessary actions and hold additional general meetings until October&nbsp;22, 2023 to obtain the approval of the Extension Proposal. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">If (i)&nbsp;the Extension Proposal is not approved and we are unable to consummate any business combination prior to or on October&nbsp;22,
2023 and (ii)&nbsp;the Lender determines not to fund any additional extension as permitted by the Existing Charter, then as contemplated by and in accordance with our Memorandum and Articles of Association, the Company will (i)&nbsp;cease all
operations except for the purpose of winding up, (ii)&nbsp;as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a <FONT STYLE="white-space:nowrap">per-share</FONT> price, payable in cash,
equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its taxes, if any (less up to $100,000 of interest to pay winding
up and dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public shareholders&#146; rights as shareholders (including the right to receive further liquidating distributions, if
any) and (iii)&nbsp;as promptly as reasonably possible following such redemption, subject to the approval of the Company&#146;s remaining shareholders and the Board, liquidate and dissolve, subject in the cases of (ii)&nbsp;and (iii), to the
Company&#146;s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable laws. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">At
such time, the Private Placement Warrants will expire and our Sponsor and the Salient Client Accounts will receive nothing upon a liquidation with respect to such Private Placement Warrants, and the Private Placement Warrants will be worthless. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The amount in the Trust Account (less approximately $2,760 representing the aggregate nominal par value of the shares of our Public
Shareholders) under the Companies Act will be treated as a share premium which is distributable under the Companies Act, provided that immediately following the date on which the proposed distribution is proposed to be made, we are able to pay our
debts as they fall due in the ordinary course of business. If we are forced to liquidate the Trust Account, we anticipate that we would distribute to our Public Shareholders the amount in the Trust Account calculated as of the date that is two days
prior to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
the distribution date (including any accrued interest). Prior to such distribution, we would be required to assess all claims that may be potentially brought against us by our creditors for
amounts they are actually owed and make provision for such amounts, as creditors take priority over our Public Shareholders with respect to amounts that are owed to them. We cannot assure you that we will properly assess all claims that may be
potentially brought against us. As such, our shareholders could potentially be liable for any claims of creditors to the extent of distributions received by them as an unlawful payment in the event we enter an insolvent liquidation. Furthermore,
while we will seek to have all vendors and service providers (which would include any third parties we engaged to assist us in any way in connection with our search for a target business) and prospective target businesses execute agreements with us
waiving any right, title, interest or claim of any kind they may have in or to any monies held in the Trust Account, there is no guarantee that they will execute such agreements. Nor is there any guarantee that, even if such entities execute such
agreements with us, they will not seek recourse against the Trust Account or that a court would conclude that such agreements are legally enforceable. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Our shareholders as of immediately prior to our IPO, including our Sponsor (our &#147;<B>Initial Shareholders</B>&#148;),<B> </B>have agreed to
waive their rights to participate in any liquidation of our Trust Account or other assets with respect to the 6,900,000 Ordinary Shares held or controlled by our Initial Shareholders prior to the Company&#146;s IPO <B>(</B>&#147;<B>Insider
Shares</B>&#148;<B> </B>or &#147;<B>insider shares</B>&#148;) and to vote their insider shares in favor of any dissolution and plan of distribution which we submit to a vote of shareholders. There will be no distribution from the Trust Account with
respect to our Private Placement Warrants, which will expire worthless. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>If the Extension Proposal is approved, what happens next? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If the Extension Proposal is approved, the Company will continue to attempt to consummate an initial business
combination until the New Extended Date, or an initial business combination until the Additional Extension Date, if applicable, or the earlier date on which the Board otherwise determines in its sole discretion that it will not be able to consummate
an initial business combination by the New Extended Date, or an initial business combination by the Additional Extension Date, if applicable, and does not wish to seek an additional extension. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">If the Extension Proposal is approved, the removal of the Withdrawal Amount from the Trust Account, if any, will reduce the amount remaining in
the Trust Account and increase the percentage interest of Company shares held by the Company&#146;s officers, directors and their affiliates. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What amount will holders receive upon consummation of a subsequent business combination or liquidation if
the Extension Proposal is approved? </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If the Extension Proposal is approved and the Extension Amendment becomes effective, within five business days
of the date of the General Meeting, the Company will make a payment from the Company&#146;s working capital account into the Trust Account of the lesser of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; or $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; for each Public Share that is outstanding
following the exercise of redemption rights in connection with the Extension Proposal. In addition, if the Extension Proposal is approved and the Extension Amendment becomes effective, in the event that the Company has not consummated an initial
business combination by the New Extended Date, without approval of the Company&#146;s shareholders, the Company may, upon five days&#146; advance notice prior to the New Extended Date extend the Termination Date up to six times (with each such
extension being upon five days&#146; advance notice), each by one additional month (for a total of up to six additional months to complete a business combination), provided that a Lender will deposit into the Trust Account for each Additional
Extension Date the lesser of (a)&nbsp;US$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; or (b) $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; for
each Public Share that is then-outstanding, in exchange for one or more <FONT STYLE="white-space:nowrap">non-interest</FONT> bearing, unsecured promissory notes issued by the Company to the Lender. If the Company completes its initial business
combination, it will, at the option of the Lender, repay the amounts loaned under the promissory note(s) or convert a portion or all of the amounts loaned under such promissory note(s) into warrants at a price of $1.00 per warrant, which warrants
will be identical to the Private Placement Warrants issued to the Sponsor and the Salient Client Accounts at the time of the Company&#146;s IPO. If the Company does not complete a </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
business combination by the deadline to consummate an initial business combination, such promissory notes will be repaid only from funds held outside of the Trust Account. </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">The deposits are conditioned upon the approval of the Extension Proposal and the filing of the Extension Amendment immediately following the
initial deposit. The deposits will not occur if the Extension Proposal is not approved. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Would I still be able to exercise my redemption rights in the future if I vote against any subsequently
proposed business combination? </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Unless you elect to redeem your shares in connection with this shareholder vote to approve the Extension
Proposal, you will be able to vote on a subsequently proposed initial business combination when it is submitted to Shareholders. If you disagree with a potential initial business combination, you will retain your right to vote against it and/or
redeem your Public Shares upon consummation of the initial business combination in connection with the shareholder vote to approve such business combination, subject to any limitations set forth in the Existing Charter. </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>How do I change my vote? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If you have submitted a proxy to vote your shares and wish to change your vote, or revoke your proxy, you may
do so by delivering a later-dated, signed proxy card to: </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Morrow Sodali </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Toll-Free (800) <FONT STYLE="white-space:nowrap">662-5200</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Email: ESAC.info@investor.morrowsodali.com </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>How are votes counted? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Company&#146;s proxy solicitor, Morrow Sodali LLC, will be appointed as inspector of election for the
meeting. Votes will be counted by the inspector of election, who will separately count &#147;FOR&#148; and &#147;AGAINST&#148; votes, abstentions, and broker <FONT STYLE="white-space:nowrap">non-votes.</FONT> </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Extension Proposal. </B>The Extension Proposal must be approved by a special resolution as a matter of Cayman Islands law, being the
affirmative vote of at least a <FONT STYLE="white-space:nowrap">two-thirds</FONT> majority of the votes cast by the holders of the Ordinary Shares who are present in person (including virtually) or represented by proxy and entitled to vote at the
General Meeting. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Adjournment Proposal. </B>The Adjournment Proposal must be approved by an ordinary resolution as a matter of Cayman
Islands law, being the affirmative vote of a majority of the votes cast by the holders of the Ordinary Shares who are present in person (including virtually) or represented by proxy and entitled to vote at the General Meeting. Abstentions and broker
<FONT STYLE="white-space:nowrap">non-votes,</FONT> while considered present for the purposes of establishing a quorum, are not treated as votes cast and will have no effect on the proposals. As a result, if you abstain from voting on any of the
proposals, your shares will be counted as present for purposes of establishing a quorum (if so present in accordance with the terms of our Existing Charter), but the abstention will have no effect on the outcome of such proposal. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>If my shares are held in &#147;street name&#148; by my bank, brokerage firm or nominee, will they
automatically vote my shares for me? </B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No. If you are a beneficial owner and you do not provide voting instructions to your broker, bank or other
holder of record holding shares for you, your shares will not be voted with respect to any proposal for which your broker does not have discretionary authority to vote. If a proposal is determined to be discretionary, your broker, bank or other
holder of record is permitted to vote on the proposal without receiving voting instructions from you. If a proposal is determined to be <FONT STYLE="white-space:nowrap">non-discretionary,</FONT> your broker, bank or other holder of record is not
permitted to vote on the proposal without receiving voting instructions from you. The Company believes that the Extension Proposal and the Adjournment Proposal will be considered </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
<FONT STYLE="white-space:nowrap">non-discretionary</FONT> and therefore <I>your broker, bank or other holder of record holding your shares for you cannot vote your shares without your instruction
on any of the proposals presented.</I> A &#147;broker <FONT STYLE="white-space:nowrap">non-vote&#148;</FONT> occurs when a bank, broker or other holder of record holding shares for a beneficial owner does not vote on a
<FONT STYLE="white-space:nowrap">non-discretionary</FONT> Proposal because the holder of record has not received voting instructions from the beneficial owner. As we do not believe that any of the Proposals are discretionary, if you do not provide
voting instructions to your broker, bank of other holder of record, there will be no Proposals on which your shares may be voted. </TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Abstentions and broker <FONT STYLE="white-space:nowrap">non-votes,</FONT> while considered present for the purposes of establishing a quorum,
are not treated as votes cast and will have no effect on the proposals. As a result, if you abstain from voting on any of the proposals, your shares will be counted as present for purposes of establishing a quorum (if so present in accordance with
the terms of our Existing Charter), but the abstention will have no effect on the outcome of such proposal. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What will happen if I abstain from voting or fail to vote at the General Meeting? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">At the General Meeting, ESGEN will count a properly executed proxy marked &#147;ABSTAIN&#148; with respect to a
particular proposal as present for purposes of determining whether a quorum is present. Abstentions will have no effect on the outcome of the vote on any of the proposals. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">If a shareholder who holds share in &#147;street name&#148; does not give the broker voting instructions, the broker is not permitted under
applicable self-regulatory organization rules to vote the shares on <FONT STYLE="white-space:nowrap">&#147;non-routine&#148;</FONT> proposals, such as the Extension Proposal. These &#147;broker <FONT STYLE="white-space:nowrap">non-votes&#148;</FONT>
will also count as present for purposes of determining whether a quorum is present and will have no effect on the outcome of the vote on any of the Proposals. However, as we do not believe that any of the Proposals are discretionary, if you do not
provide voting instructions to your broker, bank of other holder of record, there will be no Proposals on which your shares may be voted. Accordingly, there may be broker <FONT STYLE="white-space:nowrap">non-votes</FONT> and your shares may be
counted for purposes of a quorum. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What will happen if I sign and return my proxy card without indicating how I wish to vote?
</B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Signed and dated proxies received by ESGEN without an indication of how the shareholder intends to vote on a
proposal will be voted as recommended by the Board. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>If I am not going to attend the General Meeting, should I return my proxy card instead?
</B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Yes. Whether you plan to attend the General Meeting virtually or not, please read the proxy statement
carefully, and vote your shares by completing, signing, dating and returning the enclosed proxy card in the postage-paid envelope provided. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>May I change my vote after I have mailed my signed proxy card? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Yes. You may change your vote at any time before your proxy is voted at the General Meeting. You may revoke
your proxy by executing and returning a proxy card dated later than the previous one, or by voting again via the Internet, or by submitting a written revocation stating that you would like to revoke your proxy that our proxy solicitor receives prior
to the General Meeting. If you hold your Ordinary Shares through a bank, brokerage firm or nominee, you should follow the instructions of your bank, brokerage firm or nominee regarding the revocation of proxies. If you are a record holder, you
should send any notice of revocation or your completed new proxy card, as the case may be, to: </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Morrow Sodali LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Toll-Free (800) 662-5200 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Email:
ESAC.info@investor.morrowsodali.com </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Unless revoked, a proxy will be voted at the General Meeting in accordance with the
shareholder&#146;s indicated instructions. In the absence of instructions, proxies which have been signed and returned will be voted FOR each of the Extension Proposal and the Adjournment Proposal. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What should I do if I receive more than one set of voting materials? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">You may receive more than one set of voting materials, including multiple copies of this proxy statement and
multiple proxy cards or voting instruction cards. For example, if you hold your shares in more than one brokerage account, you will receive a separate voting instruction card for each brokerage account in which you hold shares. If you are a holder
of record and your shares are registered in more than one name, you will receive more than one proxy card. Please complete, sign, date and return each proxy card and voting instruction card that you receive in order to cast your vote with respect to
all of your shares. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What is a quorum requirement? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">A quorum of Shareholders is necessary to hold a valid meeting. Holders of at least <FONT
STYLE="white-space:nowrap">one-third</FONT> of the issued shares entitled to vote at the General Meeting, present in person (including virtually) or represented by proxy, constitute a quorum. In the absence of a quorum, the General Meeting will
either stand adjourned to the same day/time/place in the following week or will be adjourned to such other day/time/place as the board of directors decides. As of the Record Date for the General
Meeting,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Ordinary Shares, in the aggregate, would be required to achieve a quorum. </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Who can vote at the General Meeting? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Only holders of record of the Company&#146;s Ordinary Shares at the close of business on September&nbsp;13,
2023 are entitled to have their vote counted at the General Meeting and any adjournments or postponements thereof. For the purposes of this Proxy Statement &#147;holders of record&#148; means the persons entered in the register of members of the
Company as the holders of the relevant shares. On the Record Date, there were&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;outstanding Ordinary Shares of the Company. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Shareholder of Record: Shares Registered in Your Name. </B>If on the Record Date your shares were registered directly in your name with the
Company&#146;s transfer agent, Continental Stock Transfer&nbsp;&amp; Trust Company, then you are a shareholder of record. As a shareholder of record, you may vote in person (including virtually) at the General Meeting or vote by proxy. Whether or
not you plan to attend the General Meeting virtually, we urge you to fill out and return the enclosed proxy card to ensure your vote is counted. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>Beneficial Owner: Shares Registered in the Name of a Broker or Bank. </B>If on the Record Date your shares were held, not in your name, but
rather in an account at a brokerage firm, bank, dealer, or other similar organization, then you are the beneficial owner of shares held in &#147;street name&#148; and these proxy materials are being forwarded to you by that organization. As a
beneficial owner, you have the right to direct your broker or other agent on how to vote the shares in your account. You are also invited to attend the General Meeting. However, since you are not the shareholder of record, you may not vote your
shares in person at the General Meeting unless you request and obtain a valid proxy from your broker or other agent. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Does the Board recommend voting for the Extension Proposal and the Adjournment Proposal?
</B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Yes. The Board recommends that the Company&#146;s Shareholders vote &#147;FOR&#148; the Extension Proposal and
&#147;FOR&#148; the Adjournment Proposal. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What interests do the Company&#146;s directors and officers have in the approval of the Extension Proposal?
</B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Company&#146;s directors, officers and their affiliates have interests in the Extension Proposal that may
be different from, or in addition to, your interests as a shareholder. These interests include, but are not limited to, (i)&nbsp;the fact that James P. Benson will be the Sponsor&#146;s designee to the board of directors of the combined
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
company (&#147;<B>Combined Company Board</B>&#148;) upon the closing of the Business Combination and (ii)&nbsp;the beneficial ownership of Insider Shares and Private Placement Warrants becoming
worthless if the Extension Proposal is not approved. See the section entitled <I>&#147;Interests of the Company&#146;s Directors and Officers.&#148;</I> </TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What if I object to the Extension Proposal? Do I have appraisal or dissenters&#146; rights?
</B></P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Company Shareholders do not have appraisal rights in connection with the Extension Proposal. As a matter of
Cayman Islands law, dissenters&#146; rights are only applicable in a statutory merger involving the Company which is not the case with the Extension Proposal. </P></TD></TR></TABLE>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>What do I need to do now? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">You are urged to read carefully and consider the information contained in this proxy statement and to consider
how the proposals will affect you as a shareholder. You should then vote as soon as possible in accordance with the instructions provided in this proxy statement and on the enclosed proxy card or, if you hold your shares through a brokerage firm,
bank or other nominee, on the voting instruction form provided by the broker, bank or nominee. </P></TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>How do I redeem my Ordinary Shares of the Company? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In connection with the General Meeting and the vote on the Extension Proposal, each Public Shareholder may seek
to redeem its Public Shares for a pro rata portion of the funds available in the Trust Account, less any taxes we anticipate will be owed on such funds but have not yet been paid. Holders of Public Shares do not need to vote on the Extension
Proposal or be a holder of record on the Record Date to exercise redemption rights. </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">To demand redemption, if you hold
physical certificates for Ordinary Shares, you must physically tender your share certificates to Continental Stock Transfer&nbsp;&amp; Trust Company, the Company&#146;s transfer agent, at Continental Stock Transfer&nbsp;&amp; Trust Company, One
State Street Plaza, 30th Floor, New York, NY 10004, Attn: Mark Zimkind, <FONT STYLE="white-space:nowrap">E-mail:</FONT> mzimkind@continentalstock.com, no later than two business days prior to the General Meeting. If you hold your Ordinary Shares in
&#147;street name&#148; through a bank, broker or other nominee, you must tender or deliver your shares (and share certificates (if any) and other redemption forms) to Continental Stock Transfer&nbsp;&amp; Trust Company electronically using The
Depository Trust Company&#146;s DWAC (Deposit/Withdrawal At Custodian) System two business days prior to the General Meeting to demand redemption. You will only be entitled to receive cash in connection with a redemption of these shares if you
continue to hold them until the effective date of the Extension Amendment. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Who will solicit and pay the cost of soliciting proxies? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">ESGEN will pay the cost of soliciting proxies for the General Meeting. ESGEN has engaged Morrow Sodali LLC, to
assist in the solicitation of proxies for the General Meeting. ESGEN has agreed to pay Morrow Sodali LLC a fee of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, plus disbursements. ESGEN will
reimburse Morrow Sodali LLC for reasonable <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses and will indemnify Morrow Sodali LLC and its affiliates against certain claims, liabilities, losses,
damages and expenses. ESGEN will also reimburse banks, brokers and other custodians, nominees and fiduciaries representing beneficial owners of Ordinary Shares for their expenses in forwarding soliciting materials to beneficial owners of Ordinary
Shares and in obtaining voting instructions from those owners. ESGEN&#146;s directors, officers and employees may also solicit proxies by telephone, by facsimile, by mail, on the Internet or in person. They will not be paid any additional amounts
for soliciting proxies. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>Q:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Who can help answer my questions? </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">A:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">If you have questions about the Extension Proposal or the Adjournment Proposal or if you need additional copies
of this proxy statement or the enclosed proxy card, you should contact ESGEN&#146;s proxy solicitor at: </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Morrow Sodali LLC
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Toll-Free (800) <FONT STYLE="white-space:nowrap">662-5200</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Email: <U>ESAC.info@investor.morrowsodali.com</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">You may also obtain additional information about ESGEN from documents filed with the SEC by following the instructions in the section titled
<I>&#147;Where You Can Find More Information.&#148;</I> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FORWARD-LOOKING STATEMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We believe it is important to communicate our expectations to our shareholders. However, there may be events in the future that we are not
able to predict accurately or over which we have no control. The cautionary language discussed in this proxy statement provide examples of risks, uncertainties and events that may cause actual results to differ materially from the expectations
described by us in such forward-looking statements, including, among other things, claims by third parties against the Trust Account, unanticipated delays in the distribution of the funds from the Trust Account and the Company&#146;s ability to
finance and consummate a business combination following the distribution of funds from the Trust Account. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this proxy statement and
to consider the risks, uncertainties and events discussed in this proxy statement, in addition to the risk factors set forth in our other filings with the SEC, including the final prospectus related to the Company&#146;s IPO dated October&nbsp;19,
2021 and initially filed with the SEC on September&nbsp;28, 2021 pursuant to Rule 424(b)(4) <FONT STYLE="white-space:nowrap">(File&nbsp;No.&nbsp;333-259836),</FONT> and the Company&#146;s Annual Report on Form
<FONT STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2022 filed with the SEC on March&nbsp;31, 2023. The documents we file with the SEC, including those referred to above, also discuss some of the risks that could
cause actual results to differ from those contained or implied in the forward-looking statements. See &#147;<I>Where You Can Find More Information</I>&#148; for additional information about our filings. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All forward-looking statements included herein attributable to the Company or any person acting on the Company&#146;s behalf are expressly
qualified in their entirety by the cautionary statements contained or referred to in this section. Except to the extent required by applicable laws and regulations, the Company undertakes no obligation to update these forward-looking statements to
reflect events or circumstances after the date of this proxy statement or to reflect the occurrence of unanticipated events. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BACKGROUND </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The Company </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">ESGEN is a blank check
company incorporated on April&nbsp;19, 2021 as a Cayman Islands exempted company. We were incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business
combination with one or more businesses, which we refer to as our initial business combination. Global economic growth, population increases and expanded access to energy are driving demand for energy resources. We believe <FONT
STYLE="white-space:nowrap">low-impact</FONT> production, transportation, and consumption of energy, as well as carbon mitigation strategies, will be critical to ensure a sustainable future. We intend to primarily target opportunities in the North
American energy and infrastructure value chain and contiguous industries that we believe will fundamentally change the current energy landscape by accelerating a shift to a <FONT STYLE="white-space:nowrap">low-carbon</FONT> future, an objective we
call &#147;Disruptive Decarbonization.&#148; There is an extensive universe of private companies that have established themselves as market leaders in Disruptive Decarbonization <FONT STYLE="white-space:nowrap">sub-segments</FONT> and that we
anticipate will benefit from access to public markets and a partnership with a platform such as ours. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We identified several specific
sectors on which we intend to focus on including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">electrification, clean fuel production and transportation, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">energy efficiency and resource management </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">environmental impact mitigation and carbon sequestration </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">While Disruptive Decarbonization target opportunities will be our primary focus, we may pursue an initial business combination with any
business in any industry and any geographic location within North America. We intend to target companies that are committed to environmental, social and governance practices as a way to achieve long-term competitive advantages. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On October&nbsp;22, 2021, the Company consummated its IPO of 27,600,000 Units (the &#147;<B>Units</B>&#148;) and the sale of 14,040,000
Private Placement Warrants each exercisable to purchase one Class&nbsp;A ordinary share at $11.50 per share, at a price of $1.00 per Private Placement Warrant in the Private Placement that closed simultaneously with the Company&#146;s IPO. Following
the consummation of the Company&#146;s IPO, a total of $281,520,000 of the net proceeds from the Company&#146;s IPO and the Private Placement were deposited in the Trust Account established for the benefit Public Shareholders. Our Existing Charter
provides for the return of the Company&#146;s IPO proceeds held in the Trust Account to the holders of Public Shares if there is no qualifying business combination(s) consummated on or before October&nbsp;22, 2023. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On January&nbsp;18, 2023, at an extraordinary general meeting of our shareholders, our shareholders approved the First Extension. In
connection with the First Extension, shareholders holding 24,703,445 Class&nbsp;A ordinary shares of ESGEN exercised their right to redeem their shares for cash at a redemption price of approximately $10.35 per share, for an aggregate redemption
amount of approximately $254,198,449. As of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2023, there was
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; in the Trust Account. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The mailing
address of our principal executive office is 5956 Sherry Lane, Suite 1400, Dallas, Texas 75225. Our telephone number is (214) <FONT STYLE="white-space:nowrap">987-6100.</FONT> </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The Business Combination Agreement </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On
April&nbsp;19, 2023, ESGEN, OpCo, Sunergy, the Sunergy equityholders set forth on the signature pages thereto, for limited purposes, Sponsor, and for limited purposes, Timothy Bridgewater, an individual, in his capacity as the Sellers
Representative, entered into the Business Combination Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>The Business Combination </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Business Combination Agreement and the Business Combination were unanimously approved by the board of directors of ESGEN and the board of
managers of Sunergy. The Business Combination Agreement provides for, among other things, the following transactions: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">following any Public Share Redemptions (as defined below) of Class&nbsp;A ordinary shares, each outstanding
Class&nbsp;B ordinary share will convert into one Class&nbsp;A ordinary share (the &#147;ESGEN <B>Share Conversion</B>&#148;); provided, that if the holders of Class&nbsp;B ordinary shares are required to forfeit any Class&nbsp;B ordinary shares
pursuant to the Business Combination Agreement, then the number of Class&nbsp;A ordinary shares otherwise deliverable to the holders of Class&nbsp;B ordinary shares pursuant to the ESGEN Share Conversion shall be reduced (pro rata between the
holders of Class&nbsp;B ordinary shares) by an amount equal to such forfeited Class&nbsp;B ordinary shares; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">subject to prior receipt of the requisite approval of the shareholders of ESGEN as contemplated in the Business
Combination Agreement, ESGEN will change the jurisdiction of its incorporation by deregistering as an exempted company in the Cayman Islands and domesticating to, and continuing as a corporation incorporated under the laws of, the State of Delaware
(the &#147;<B>Domestication</B>&#148;) and, in connection with the Domestication, the following will occur: (A)&nbsp;each outstanding Class&nbsp;A ordinary share will become one share of Class&nbsp;A common stock, par value $0.0001 per share, of
ESGEN (the &#147;<B>ESGEN Class</B><B></B><B>&nbsp;A Common Stock</B>&#148;), (B) each outstanding warrant to purchase one Class&nbsp;A ordinary share (each, an &#147;<B>ESGEN Warrant</B>&#148;) will become a warrant to purchase one share of ESGEN
Class&nbsp;A Common Stock at an exercise price of $11.50 per share and (C)&nbsp;ESGEN will file its certificate of incorporation substantially in the form attached to the Business Combination Agreement as Exhibit F (the &#147;<B>ESGEN Certificate of
Incorporation</B>&#148;) and will adopt bylaws substantially in the form attached to the Business Combination Agreement as Exhibit G to serve as its governing documents upon consummation of the Domestication. In connection with the ESGEN Share
Conversion and the Domestication, each issued and outstanding Unit that has not been previously separated into the underlying Class&nbsp;A ordinary share and underlying ESGEN Warrants prior to the Domestication will be cancelled and will entitle the
holder thereof to (x)&nbsp;one share of ESGEN Class&nbsp;A Common Stock and <FONT STYLE="white-space:nowrap">(y)&nbsp;one-half</FONT> of one warrant representing the right to purchase one share of ESGEN Class&nbsp;A Common Stock at an exercise price
of $11.50 per share on the terms and subject to the conditions applicable to ESGEN Warrants set forth in the Warrant Agreement, dated as of October&nbsp;22, 2021, between ESGEN and Continental Stock Transfer&nbsp;&amp; Trust Company (the
&#147;<B>Trustee</B>&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">ESGEN will cause certain private placements to be consummated in accordance with the terms of the applicable
financing agreements; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Sunergy will cause all holders of any options, warrants or rights to subscribe for or purchase any equity
interests of Sunergy or its subsidiaries or securities (including debt securities) convertible into or exchangeable for, or that otherwise confer on the holder any right to acquire, any equity interests of Sunergy or any subsidiary thereof
(collectively, the &#147;<B>Sunergy Convertible Interests</B>&#148;) existing immediately prior to the closing of the Business Combination (the &#147;<B>Closing</B>&#148;) either to exchange or convert all such holder&#146;s Sunergy Convertible
Interests into limited liability interests of Sunergy (the &#147;<B>Sunergy Company Interests</B>&#148;) in accordance with the governing documents of Sunergy or the Sunergy Convertible Interests (collectively, the &#147;<B>Sunergy
Exchanges</B>&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">(x) ESGEN will contribute to OpCo (1)&nbsp;all of its assets (excluding its interests in OpCo, but including the
amount of cash in the Trust Account as of immediately prior to the Closing (after giving effect to the exercise of redemption rights by any ESGEN shareholders pursuant to the Existing Charter (the &#147;<B>Public Share Redemption</B>&#148;)) and the
proceeds resulting from the initial PIPE investment and any financing agreements executed in furtherance of the Business Combination Agreement less the amount of certain unpaid transaction expenses), and (2)&nbsp;a number of newly issued shares of
Class&nbsp;V common stock of ESGEN, par value $0.0001 per share, which will generally have only voting rights, equal to the number of Seller OpCo Units (as defined in the Business Combination Agreement and further
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
described below) (the &#147;<B>Seller Class</B><B></B><B>&nbsp;V Shares</B>&#148;) and (y)&nbsp;in exchange, OpCo shall issue to ESGEN (i)&nbsp;a number of common units of OpCo (the &#147;<B>OpCo
Units</B>&#148;) which shall equal the number of total shares of ESGEN Class&nbsp;A Common Stock issued and outstanding immediately after the Closing and (ii)&nbsp;a number of warrants to purchase OpCo Units which shall equal the number of ESGEN
Warrants issued and outstanding immediately after the Closing (the transactions in this clause (v), the &#147;<B>ESGEN Contribution</B>&#148;); and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">immediately following the ESGEN Contribution, (x)&nbsp;the Sellers will contribute to OpCo the Sunergy Company
Interests and (y)&nbsp;in exchange therefor, OpCo will transfer to the Sellers the Seller OpCo Units and the Seller Class&nbsp;V Shares. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The number of Seller OpCo Units to be issued in the ESGEN Contribution will equal that number of OpCo Units with a value (valuing each OpCo
Unit equal to $10.00) equal to (i) $410,000,000, plus (ii)&nbsp;the amount (if any) of any financing contemplated by the financing agreements that is equity financing for equity of Sunergy or Sunergy Convertible Interests and is converted to Sunergy
Company Interests as part of the Sunergy Exchanges, minus (iii)&nbsp;any Sunergy Recapitalization Debt (as defined below). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Representations and
Warranties; Covenants </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Business Combination Agreement contains representations and warranties of certain of the parties thereto
customary for transactions of this type. The representations and warranties made under the Business Combination Agreement will not survive the Closing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Between the entry into the Business Combination Agreement and the Closing, Sunergy may, with ESGEN&#146;s consent, incur debt financing and
distribute such proceeds to the Sellers or redeem Sunergy Company Interests with proceeds thereof (&#147;<B>Sunergy Recapitalization Debt</B>&#148;), subject to certain limitations set forth in the Business Combination Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Business Combination Agreement contains representations, warranties and covenants that the respective parties made to each other as of the
date of the Business Combination Agreement or other specific dates, as specified therein. The assertions embodied in those representations, warranties and covenants were made for purposes of the contract among the respective parties and are subject
to important qualifications and limitations agreed to by the parties in connection with negotiating such agreement. The representations, warranties and covenants in the Business Combination Agreement are also modified in important part by the
underlying disclosure schedules which are not filed publicly and which are subject to a contractual standard of materiality different from that generally applicable to shareholders and were used for the purpose of allocating risk among the parties
rather than establishing matters as facts. ESGEN does not believe that these schedules contain information that is material to an investment decision. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, the parties to the Business Combination Agreement agreed to be bound by certain covenants customary for transactions of this
type, including, among others, covenants with respect to the conduct and operations of ESGEN, Sunergy and its subsidiaries during the period between signing the Business Combination Agreement and the Closing. ESGEN has also agreed to take all action
within its power as may be necessary or appropriate such that, immediately after the Closing, the Combined Company Board will consist of seven directors, six of whom will be designated by Sunergy and one of whom will be designated by the Sponsor
(with three of such Sunergy designees meeting the requirements for audit committee service pursuant to the listing rules of the Nasdaq Stock Market LLC (&#147;<B>Nasdaq</B>&#148;)), Rule <FONT STYLE="white-space:nowrap">10A-3</FONT> of the
Securities Exchange Act of 1934, as amended (the &#147;<B>Exchange Act</B>&#148;), and the Sarbanes-Oxley Act of 2002, as amended. Each of the parties to the Business Combination Agreement has also agreed to use its respective reasonable best
efforts to cause the Business Combination to be consummated after the date of the execution of the Business Combination Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Conditions to Each Party&#146;s Obligations </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The obligation of ESGEN, the Sunergy Parties and OpCo to consummate the Business Combination is subject to certain customary closing
conditions, including, but not limited to, (i)&nbsp;the absence of any order, law or other legal restraint or prohibition enacted, issued or promulgated by any court of competent jurisdiction or other governmental entity of competent jurisdiction
having the effect of making the Business Combination illegal or otherwise prohibiting the consummation of the Business Combination, (ii)&nbsp;the termination or expiration of any applicable waiting period applicable to the consummation of the
Business Combination under the Hart-Scott-Rodino Act, (iii)&nbsp;the effectiveness of the Registration Statement on Form <FONT STYLE="white-space:nowrap">S-4</FONT> (the &#147;<B>Registration Statement</B>&#148;) in accordance with the provisions of
the Securities Act of 1933, as amended, registering the ESGEN Class&nbsp;A Common Stock to be issued in connection with the Business Combination Agreement, (iv)&nbsp;receipt of the required approvals of ESGEN&#146;s shareholders at a meeting of the
shareholders of ESGEN in connection with the Business Combination (the &#147;<B>Business Combination</B> <B>Shareholders</B><B>&#146;</B><B> Meeting</B>&#148;), (v) the ESGEN Class&nbsp;A Common Stock to be issued in connection with the Business
Combination immediately after Closing shall be listed on Nasdaq and ESGEN will be able to satisfy any continued listing requirements of Nasdaq immediately after Closing, (vi)&nbsp;if the ESGEN shareholders do not approve the Redemption Limitation
Amendment (as defined in the Business Combination Agreement), ESGEN having at least $5,000,001 of net tangible assets (as determined in accordance with Rule <FONT STYLE="white-space:nowrap">3a51-1(g)(1)</FONT> of the Exchange Act) remaining
immediately after any holders of the Class&nbsp;A ordinary shares exercise their redemption rights, (vii)&nbsp;the members of the post-Business Combination ESGEN board of directors shall have been elected or appointed in accordance with the Business
Combination Agreement and (viii)&nbsp;the aggregate transaction proceeds, including from the Trust Account after giving effect to the Public Share Redemption and the proceeds resulting from the initial PIPE investment and any financing agreements
executed in furtherance of the Business Combination Agreement, shall (after payment of certain unpaid transaction expenses) be greater or equal to $20.0&nbsp;million. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The obligation of ESGEN and OpCo to consummate the Business Combination is further conditioned upon (i)&nbsp;the accuracy (within specified
thresholds) as of the Closing of the Sunergy Parties&#146; representations and warranties and material compliance by the Sunergy Parties with their respective covenants and (ii)&nbsp;the absence of a material adverse effect on Sunergy since the date
of the Business Combination Agreement that is continuing and uncured. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additionally, the obligations of the Sunergy Parties to consummate
the Business Combination are further conditioned upon (i)&nbsp;the accuracy (within specified thresholds) as of the Closing of ESGEN&#146;s and OpCo&#146;s respective representations and warranties and material compliance by ESGEN and OpCo with its
respective covenants, (ii)&nbsp;the absence of a material adverse effect on ESGEN since the date of the Business Combination Agreement that is continuing and uncured, (iii)&nbsp;ESGEN having arranged with the Trustee to have the funds remaining in
the Trust Account released to it as of the Closing, and all such funds released being available for immediate use for any payment obligations arising from the Public Share Redemption and other required expenses and (iv)&nbsp;occurrence of the ESGEN
Share Conversion, the Domestication and the Public Share Redemption and the consummation of the Private Placements (as defined below). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Termination
</I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Business Combination Agreement may be terminated under certain limited circumstances prior to the closing of the Business
Combination, including (i)&nbsp;by mutual written consent of ESGEN and Sunergy, (ii)&nbsp;by ESGEN, on the one hand, or Sunergy, on the other hand, as a result of certain breaches of the Business Combination Agreement that remain uncured after any
applicable cure period, (iii)&nbsp;subject to certain limited exceptions, by either ESGEN or Sunergy if the Closing has not occurred by October&nbsp;22, 2023 (provided, that if the Extension Amendment is approved, then the outside date for the
Business Combination Agreement will automatically be extended for one or more additional periods up to an additional three months (or, if sooner, the last day for ESGEN to consummate a business combination pursuant to such extension)), (iv) by
either ESGEN or Sunergy if certain required approvals are not obtained from ESGEN&#146;s shareholders after the Business Combination Shareholders&#146; Meeting has been held and the shareholders have duly voted, (v)&nbsp;by either ESGEN or
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Sunergy if any governmental authority of competent jurisdiction has enacted, issued, promulgated, enforced or entered any final and nonappealable injunction, order, decree or ruling making the
consummation of the Business Combination illegal or otherwise preventing or prohibiting the consummation of the Business Combination, (vi)&nbsp;by Sunergy, if the Class&nbsp;A ordinary shares become delisted from Nasdaq and are not relisted on
Nasdaq (or another national securities exchange mutually agreed to by ESGEN and Sunergy) within thirty days after such delisting, (vii)&nbsp;by Sunergy, if the board of directors of ESGEN changes, withdraws, qualifies or modifies, or publicly
proposes to change, withdraw, qualify or modify, the recommendation of the board of directors of ESGEN to approve certain required approvals pursuant to the exercise of its fiduciary duties, and (viii)&nbsp;by Sunergy, upon the liquidation (or
public announcement thereof) of the Trust Account if ESGEN fails in connection with any extension of its deadline to consummate a business combination to timely pay any amounts required to be deposited into the Trust Account in accordance with the
terms of ESGEN&#146;s organizational documents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the Business Combination Agreement is terminated, none of the parties to the Business
Combination Agreement will have any liability under the Business Combination Agreement, except in the case of Fraud (as defined in the Business Combination Agreement) or willful and material breach of any covenant or agreement in the Business
Combination Agreement and for customary obligations that survive the termination thereof (such as confidentiality obligations). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Payment of Transaction
Expenses </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Generally, all expenses incurred in connection with the Business Combination Agreement will be paid by the party incurring
such expenses. If the Closing does occur, ESGEN will pay all accrued and unpaid transaction expenses of ESGEN and Sunergy and will retain any remaining aggregate transaction proceeds on the balance sheet of OpCo or Sunergy. If such accrued and
unpaid expenses, excluding any existing loans to ESGEN from the Sponsor or other affiliates (&#147;<B>Affiliate Loans</B>&#148;), exceed $15&nbsp;million, then the Sponsor and all other holders of Class&nbsp;B ordinary shares, including the current
independent directors of ESGEN, will forfeit a pro rata number of ESGEN Class&nbsp;B ordinary shares (each with a value of $10.00 per Class&nbsp;B ordinary share) with an aggregate value equal to (i)&nbsp;the amount by which the total accrued and
unpaid expenses exceeds $15&nbsp;million, minus (ii) (x) $1.5&nbsp;million in Affiliate Loans, if the aggregate amount of Affiliate Loans is equal to or in excess of $1.5&nbsp;million, or (y)&nbsp;the amount of Affiliate Loans, if the aggregate
amount of Affiliate Loans is less than $1.5&nbsp;million (such difference between (i)&nbsp;and (ii), the &#147;<B>Sponsor Covered Expenses</B>&#148;). The Sponsor Covered Expenses will be reduced to the extent that transaction expenses attributable
to Sunergy exceed $5&nbsp;million by the amount such Sunergy expenses exceed $5&nbsp;million. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Incentive Equity Plan </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to the effectiveness of the Registration Statement, the board of directors of ESGEN will approve and adopt an equity incentive plan (the
&#147;<B>Incentive Equity Plan</B>&#148;) in the form mutually agreed upon by Sunergy and ESGEN to be effective as of one day prior to the Closing. The Incentive Equity Plan will provide for an initial share reserve of 8% of the number of shares of
ESGEN Class&nbsp;A Common Stock outstanding following the Closing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROPOSAL 1 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE EXTENSION PROPOSAL </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The Extension
Proposal </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company is proposing to amend its Existing Charter (such amendment, the &#147;<B>Extension Amendment</B>&#148;) to:
(i)&nbsp;extend from October&nbsp;22, 2023 (the &#147;<B>Original Extended Date</B>&#148;) to January&nbsp;22, 2024 (the &#147;<B>New Extended Date</B>&#148;),<B> </B>the date (the &#147;<B>Termination Date</B>&#148;) by which, if the Company has
not consummated a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination involving one or more businesses or entities, the Company must: (a)&nbsp;cease all operations except for the
purpose of winding up; (b)&nbsp;as promptly as reasonably possible but not more than ten business days thereafter, redeem the shares sold in the Company&#146;s initial public offering (the &#147;<B>Public Shares</B>&#148;) (in a redemption that will
completely extinguish the rights of the owners of the Public Shares as shareholders (including the right to receive further liquidation distributions, if any)) at a <FONT STYLE="white-space:nowrap">per-share</FONT> price, payable in cash, equal to
(1)&nbsp;the aggregate amount then on deposit in the trust account located in the United States with Continental Stock Transfer&nbsp;&amp; Trust Company acting as trustee (&#147;<B>Trust Account</B>&#148;), including interest earned on the funds
held in the Trust Account and not previously released to the Company to pay its income taxes, if any, less up to $100,000 of interest to pay winding up and dissolution expenses (net of any taxes payable), divided by (2)&nbsp;the number of the
then-outstanding Public Shares; and (c)&nbsp;as promptly as reasonably possible following such redemption, subject to the approval of the Company&#146;s remaining shareholders and the Board, liquidate and dissolve, subject in the case of clauses
(b)&nbsp;and (c) to the Company&#146;s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law, and (ii)&nbsp;in the event that the Company has not consummated an initial business
combination by the New Extended Date, to allow the Company, by resolution of the board of directors of the Company and, without any approval of the Company&#146;s shareholders, upon five days&#146; advance notice prior to the New Extended Date to
extend the Termination Date up to six times (with each such extension being upon five days&#146; advance notice), each by one additional month (for a total of up to six additional months to complete a business combination) (each, an
&#147;<B>Additional Extension Date</B>&#148;), provided that the Company&#146;s sponsor, ESGEN LLC (the &#147;<B>Sponsor</B>&#148;) or the Sponsor&#146;s affiliates or permitted designees (the &#147;<B>Lenders</B>&#148; and each a
&#147;<B>Lender</B>&#148;) will deposit into the Trust Account for each Additional Extension Date the lesser of (a)&nbsp;US$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; or (b)
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; for each Public Share that is then-outstanding, in exchange for one or more <FONT STYLE="white-space:nowrap">non-interest</FONT> bearing, unsecured
promissory notes issued by the Company to the Lender. If the Company completes its initial business combination, it will, at the option of the Lender, repay the amounts loaned under the promissory note(s) or convert a portion or all of the amounts
loaned under such promissory note(s) into warrants at a price of $1.00 per warrant, which warrants will be identical to the Private Placement Warrants issued to the Sponsor and the Salient Client Accounts at the time of the Company&#146;s initial
public offering <B>(</B>&#147;<B>IPO</B>&#148;).<B> </B>If the Company does not complete a business combination by the deadline to consummate an initial business combination, such promissory notes will be repaid only from funds held outside of the
Trust Account. The Extension Proposal is essential to the overall implementation of the Board&#146;s plan to allow the Company more time to complete an initial business combination. Approval of the Extension Potential is a condition to the filing of
the Extension Amendment. A copy of the Extension Amendment to the Existing Charter of the Company is attached to this proxy statement as <B>Annex A.</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All holders of the Company&#146;s Public Shares, whether they vote for or against the Extension Proposal or do not vote at all, will be
permitted to redeem all or a portion of their Public Shares into their pro rata portion of the Trust Account, provided that the Extension Proposal is approved. Holders of Public Shares do not need to be a holder of record on the Record Date in order
to exercise redemption rights. If approved, we will not file the Extension Proposal if we do not have at least $5,000,001 of net tangible assets following approval of the Extension Proposal, after taking into account the amount of redemptions, if
any. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The <FONT STYLE="white-space:nowrap">per-share</FONT> pro rata portion of the Trust Account on the Record Date after taking into
account taxes owed but not paid by such date (which is expected to be the same approximate amount two business days prior to the General Meeting) was approximately
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per Public Share. The closing price of the Company&#146;s Ordinary Shares on the Record Date was
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;. The Company cannot assure Shareholders that they will be able to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
sell their Ordinary Shares in the open market, even if the market price per share is higher than the redemption price stated above, as there may not be sufficient liquidity in its securities when
such Shareholders wish to sell their shares. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Reasons for the Extension Proposal </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company&#146;s IPO prospectus and Existing Charter provide that the Company has until October&nbsp;22, 2023 to complete an initial business
combination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company believes that given its expenditure of time, effort, and money searching for potential business combination
opportunities, the Public Shareholders of the Company should be given an opportunity to consider and vote on an initial business combination. Accordingly, the Company has determined to seek shareholder approval to extend the time for closing a
business combination beyond October&nbsp;22, 2023. Pursuant to the terms of the Existing Charter, the Company may not amend the Existing Charter to allow for a longer period of time to complete an initial business combination unless it provides
holders of Public Shares with the right to seek redemption of their Public Shares in connection therewith. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>If the Extension Proposal Is Not Approved
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If based on the tabulated vote there are insufficient votes to approve the Extension Proposal, the Company may put the Adjournment
Proposal to a vote as the first resolution in order to seek additional time to obtain sufficient tabulated votes in support of the Extension Amendment. If the Extension Proposal is not approved at the General Meeting, we expect to take all necessary
actions and hold additional general meetings until October&nbsp;22, 2023 to obtain the approval of the Extension Proposal. If (i)&nbsp;the Extension Proposal is not approved and we are unable to consummate any business combination prior to or on
October&nbsp;22, 2023 and (ii)&nbsp;the Lender determines not to fund any additional extension as permitted by the Existing Charter, then as contemplated by and in accordance with our Memorandum and Articles of Association, the Company will
(i)&nbsp;cease all operations except for the purpose of winding up, (ii)&nbsp;as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a <FONT STYLE="white-space:nowrap">per-share</FONT> price,
payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its taxes, if any (less up to $100,000 of
interest to pay winding up and dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish public shareholders&#146; rights as shareholders (including the right to receive further
liquidating distributions, if any) and (iii)&nbsp;as promptly as reasonably possible following such redemption, subject to the approval of the Company&#146;s remaining shareholders and the Board, liquidate and dissolve, subject in the cases of
(ii)&nbsp;and (iii), to the Company&#146;s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable laws. At such time, the Private Placement Warrants will expire and our Sponsor and the
Salient Client Accounts will receive nothing upon a liquidation with respect to such Private Placement Warrants, and the Private Placement Warrants will be worthless. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The amount in the Trust Account (less approximately $2,760 representing the aggregate nominal par value of the shares of our Public
Shareholders) under the Companies Act will be treated as a share premium which is distributable under the Companies Act, provided that immediately following the date on which the proposed distribution is proposed to be made, we are able to pay our
debts as they fall due in the ordinary course of business. If we are forced to liquidate the Trust Account, we anticipate that we would distribute to our Public Shareholders the amount in the Trust Account calculated as of the date that is two days
prior to the distribution date (including any accrued interest). Prior to such distribution, we would be required to assess all claims that may be potentially brought against us by our creditors for amounts they are actually owed and make provision
for such amounts, as creditors take priority over our Public Shareholders with respect to amounts that are owed to them. We cannot assure you that we will properly assess all claims that may be potentially brought against us. As such, our
shareholders could potentially be liable for any claims of creditors to the extent of distributions received by them as an unlawful payment in the event we enter an insolvent liquidation. Furthermore, while we
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
will seek to have all vendors and service providers (which would include any third parties we engaged to assist us in any way in connection with our search for a target business) and prospective
target businesses execute agreements with us waiving any right, title, interest or claim of any kind they may have in or to any monies held in the Trust Account, there is no guarantee that they will execute such agreements. Nor is there any
guarantee that, even if such entities execute such agreements with us, they will not seek recourse against the Trust Account or that a court would conclude that such agreements are legally enforceable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Initial Shareholders, including our Sponsor, have agreed to waive their rights to participate in any liquidation of our Trust Account or
other assets with respect to the Insider Shares and to vote their Insider Shares in favor of any dissolution and plan of distribution which we submit to a vote of shareholders. There will be no distribution from the Trust Account with respect to the
Private Placement Warrants, which will expire worthless. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>If the Extension Proposal is Approved </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the Extension Proposal is approved, the Existing Charter will be amended as set forth in <B>Annex A </B>(the &#147;<B>Extension
Amendment</B>&#148;) and the Company would have up to an additional nine months after the Original Extended Date to consummate an initial business combination, until July&nbsp;22, 2024, which is a total of up to 33&nbsp;months from the consummation
of the Company&#146;s IPO to complete an initial business combination. The Company will continue to attempt to consummate an initial business combination until the New Extended Date or the Additional Extension Date, if necessary, or until the Board
determines in its sole discretion that it will not be able to consummate an initial business combination and does not wish to seek an additional extension. The Company will remain a reporting company under the Securities Exchange Act of 1934, as
amended and its Ordinary Shares will remain publicly traded during the extension period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>YOU ARE NOT BEING ASKED TO VOTE ON ANY
BUSINESS COMBINATION AT THIS TIME. IF THE EXTENSION PROPOSAL IS APPROVED AND THE EXTENSION AMENDMENT BECOMES EFFECTIVE AND YOU DO NOT ELECT TO REDEEM YOUR PUBLIC SHARES NOW, YOU WILL RETAIN THE RIGHT TO VOTE ON ANY PROPOSED BUSINESS COMBINATION WHEN
AND IF IT IS SUBMITTED TO SHAREHOLDERS AND THE RIGHT TO REDEEM YOUR PUBLIC SHARES FOR A PRO RATA PORTION OF THE TRUST ACCOUNT IN THE EVENT SUCH PROPOSED BUSINESS COMBINATION IS APPROVED AND COMPLETED. </B></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Redemption Rights </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the Extension
Proposal is approved, and the Extension Amendment becomes effective, each Public Shareholder may seek to redeem its Public Shares for a pro rata portion of the funds available in the Trust Account, less any taxes we anticipate will be owed, but have
not yet been paid, calculated as of two business days prior to the meeting. Holders of Public Shares do not need to vote on the Extension Proposal or be a holder of record on the Record Date to exercise redemption rights. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the Extension Proposal is approved, the Company will (i)&nbsp;remove from the Trust Account an amount (the &#147;<B>Withdrawal
Amount</B>&#148;) equal to the pro rata portion of funds available in the Trust Account relating to any Public Shares redeemed by holders in connection with the Extension Proposal, if any, and (ii)&nbsp;deliver to the holders of such redeemed Public
Shares their pro rata portion of the Withdrawal Amount. The remainder of such funds shall remain in the Trust Account and be available for use by the Company to complete a business combination on or before the New Extended Date or the Additional
Extension Date, if applicable. Holders of Public Shares who do not redeem their Public Shares now will retain their redemption rights and their ability to vote on a business combination through the New Extended Date, or the Additional Extension
Date, if applicable, if the Extension Proposal is approved and the Extension Amendment becomes effective. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the Extension Proposal is
approved, and the Extension Amendment becomes effective, the removal of the Withdrawal Amount from the Trust Account, if any, will reduce the Company&#146;s net asset value. The Company </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
cannot predict the amount that will remain in the Trust Account if the Extension Proposal is approved, and the amount remaining in the Trust Account may be only a small fraction of the
approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; that was in the Trust Account as of the Record Date. However, we will not proceed if we do not have at least $5,000,001 of net tangible
assets following approval of the Extension Proposal (after taking into account the redemption of Public Shares). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">TO DEMAND REDEMPTION, IF
YOU HOLD PHYSICAL CERTIFICATES FOR ORDINARY SHARES, YOU MUST PHYSICALLY TENDER YOUR SHARE CERTIFICATES TO CONTINENTAL STOCK TRANSFER&nbsp;&amp; TRUST COMPANY, THE COMPANY&#146;S TRANSFER AGENT, AT CONTINENTAL STOCK TRANSFER&nbsp;&amp; TRUST COMPANY,
ONE STATE STREET PLAZA, 30TH FLOOR, NEW YORK, NY 10004, ATTN: MARK ZIMKIND, <FONT STYLE="white-space:nowrap">E-MAIL:</FONT> <U>mzimkind@continentalstock.com</U>, NO LATER THAN TWO BUSINESS DAYS PRIOR TO THE GENERAL MEETING. IF YOU HOLD YOUR ORDINARY
SHARES IN &#147;STREET NAME&#148; THROUGH A BANK, BROKER OR OTHER NOMINEE, YOU MUST TENDER OR DELIVER YOUR SHARES (AND SHARE CERTIFICATES (IF ANY) AND OTHER REDEMPTION FORMS) TO CONTINENTAL STOCK TRANSFER&nbsp;&amp; TRUST COMPANY ELECTRONICALLY
USING THE DEPOSITORY TRUST COMPANY&#146;S DWAC (DEPOSIT/WITHDRAWAL AT CUSTODIAN) SYSTEM TWO BUSINESS DAYS PRIOR TO THE GENERAL MEETING TO DEMAND REDEMPTION. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The requirement for physical or electronic delivery prior to the vote at the General Meeting ensures that a redeeming holder&#146;s election
is irrevocable once the Extension Proposal is approved. In furtherance of such irrevocable election, Shareholders making the election will not be able to tender their shares after the vote at the General Meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The electronic delivery process through the DWAC system can be accomplished by the shareholder, whether or not it is a record holder or its
shares are held in &#147;street name,&#148; by contacting the transfer agent or its broker and requesting delivery of its shares through the DWAC system. Delivering shares physically may take significantly longer. In order to obtain a physical share
certificate, a shareholder&#146;s broker and/or clearing broker, DTC, and the Company&#146;s transfer agent will need to act together to facilitate this request. There is a nominal cost associated with the above-referenced tendering process and the
act of certificating the shares or delivering them through the DWAC system. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The transfer agent will typically charge the tendering broker
a nominal amount and the broker would determine whether or not to pass this cost on to the redeeming holder. It is the Company&#146;s understanding that shareholders should generally allot at least two weeks to obtain physical certificates from the
transfer agent. The Company does not have any control over this process or over the brokers or DTC, and it may take longer than two weeks to obtain a physical share certificate. Such Shareholders will have less time to make their investment decision
than those Shareholders that deliver their shares through the DWAC system. Shareholders who request physical share certificates and wish to redeem may be unable to meet the deadline for tendering their shares before exercising their redemption
rights and thus will be unable to redeem their shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Certificates that have not been tendered in accordance with these procedures prior
to the vote for the Extension Proposal will not be redeemed into a pro rata portion of the funds held in the Trust Account. In the event that a Public Shareholder tenders its shares and decides prior to the vote at the General Meeting that it does
not want to redeem its shares, the shareholder may withdraw the tender. If you tendered or delivered your shares (and share certificates (if any) and other redemption forms) for redemption to our transfer agent and decide prior to the vote at the
General Meeting not to redeem your shares, you may request that our transfer agent return the shares (physically or electronically). You may make such request by contacting our transfer agent at the address listed above prior to the vote at the
General Meeting. In the event that a Public Shareholder tenders shares, and the Extension Proposal is not approved or is abandoned, these shares will be redeemed in accordance with the terms of the Existing Charter promptly following the meeting, as
described elsewhere herein. The Company anticipates that a Public Shareholder who tenders shares for redemption in connection with the vote to approve the Extension Proposal would receive payment of the redemption price for such shares soon after
the filing of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Extension Proposal. The transfer agent will hold the certificates of Public Shareholders that make the election until such shares are redeemed for cash or redeemed in connection with our winding
up. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The <FONT STYLE="white-space:nowrap">per-share</FONT> pro rata portion of the Trust Account on the Record Date after taking into
account taxes owed but not paid by such date (which is expected to be the same approximate amount two business days prior to the General Meeting) was approximately
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per Public Share. The closing price of the Ordinary Shares on the Record Date was
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;. The Company cannot assure shareholders that they will be able to sell their Ordinary Shares in the open market, even if the market price per share is
higher than the redemption price stated above, as there may not be sufficient liquidity in its securities when such shareholders wish to sell their shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If you exercise your redemption rights, you will be exchanging your Ordinary Shares for cash and will no longer own the shares. You will be
entitled to receive cash for these shares only if you properly demand redemption by tendering your share certificate(s) to the Company&#146;s transfer agent prior to the vote for the Extension Proposal. If the Extension Proposal is not approved or
if it is abandoned, these shares will be redeemed in accordance with the terms of the Existing Charter promptly following the meeting as described elsewhere herein. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Required Vote </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>The Extension Proposal
must be approved by a special resolution as a matter of Cayman Islands law, being the affirmative vote of at least a <FONT STYLE="white-space:nowrap">two-thirds</FONT> majority of the votes cast by the holders of the Ordinary Shares who are present
in person (including virtually) or represented by proxy and entitled to vote at the General Meeting. Abstentions and broker <FONT STYLE="white-space:nowrap">non-votes,</FONT> while considered present for the purposes of establishing a quorum, are
not treated as votes cast and will have no effect on the Extension Proposal. As a result, if you abstain from voting on the Extension Proposal, your shares will be counted as present for purposes of establishing a quorum (if so present in accordance
with the terms of our Existing Charter), but the abstention will have no effect on the outcome of such proposal. </B></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Full Text of the Resolution
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Please see <B>Annex A</B>. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE BOARD RECOMMENDS A VOTE &#147;FOR&#148; THE EXTENSION PROPOSAL. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROPOSAL 2 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE ADJOURNMENT PROPOSAL </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Adjournment Proposal, if adopted, will approve the Chairman&#146;s adjournment of the General Meeting to a later date to permit further
solicitation of proxies. The Adjournment Proposal will only be presented to our Shareholders in the event, based on the tabulated votes, there are not sufficient tabulated votes received at the time of the General Meeting to approve the Extension
Proposal. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Consequences if the Adjournment Proposal is Not Approved </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the Adjournment Proposal is not approved by our Shareholders, the Chairman will not adjourn the General Meeting to a later date in the
event, based on the tabulated votes, there are not sufficient tabulated votes received at the time of the General Meeting to approve the Extension Proposal. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Required Vote </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Adjournment Proposal
must be approved by an ordinary resolution as a matter of Cayman Islands law, being the affirmative vote of a majority of the votes cast by the holders of the Ordinary Shares who are present in person (including virtually) or represented by proxy
and entitled to vote at the General Meeting. Abstentions and broker <FONT STYLE="white-space:nowrap">non-votes,</FONT> while considered present for the purposes of establishing a quorum, are not treated as votes cast and will have no effect on the
Extension Proposal or the Adjournment Proposal. As a result, if you abstain from voting on the Adjournment Proposal, your shares will be counted as present for purposes of establishing a quorum (if so present in accordance with the terms of our
Existing Charter), but the abstention will have no effect on the outcome of such proposal. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Full Text of the Resolution </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;RESOLVED, as an ordinary resolution, that the adjournment of the extraordinary general meeting to a time and place to be confirmed by the
Chairman of the extraordinary general meeting be ratified, approved and confirmed in all respects.&#148; </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE BOARD RECOMMENDS A VOTE
&#147;FOR&#148; ADOPTION OF THE ADJOURNMENT PROPOSAL. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>THE GENERAL MEETING </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Date, Time and Place.</I></B> The meeting will be at the offices of Kirkland&nbsp;&amp; Ellis LLP, 609 Main Street, Houston, TX 77002
and virtually at: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;. The General Meeting will be held at &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
ET on &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2023. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Voting Power; Record
Date.</I></B> You will be entitled to vote or direct votes to be cast at the General Meeting, if you owned Ordinary Shares at the close of business on September&nbsp;13, 2023, the Record Date for the General Meeting. At the close of business on the
Record Date, there were &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; outstanding Ordinary Shares each of which entitles its holder to cast one vote on the proposal. Company warrants do not carry
voting rights. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Proxies; Board Solicitation.</I></B> Your proxy is being solicited by the Board on the proposals being presented to
shareholders at the General Meeting. No recommendation is being made as to whether you should elect to redeem your shares. Proxies may be solicited in person or by telephone. If you grant a proxy, you may still revoke your proxy and vote your shares
in person at the General Meeting. Morrow Sodali LLC is assisting the Company in the proxy solicitation process for this General Meeting. The Company will pay that firm approximately $32,500 in fees, plus disbursements for such services. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Required Votes </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Extension Proposal
must be approved by a special resolution as a matter of Cayman Islands law, being the affirmative vote of at least a <FONT STYLE="white-space:nowrap">two-thirds</FONT> majority of the votes cast by the holders of the Ordinary Shares who are present
in person (including virtually) or represented by proxy and entitled to vote at the General Meeting. Abstentions and broker <FONT STYLE="white-space:nowrap">non-votes,</FONT> while considered present for the purposes of establishing a quorum, are
not treated as votes cast and will have no effect on the proposals. As a result, if you abstain from voting on any of the proposals, your shares will be counted as present for purposes of establishing a quorum (if so present in accordance with the
terms of our Existing Charter), but the abstention will have no effect on the outcome of such proposal. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Sponsor, the Salient Client
Accounts and all of the Company&#146;s directors, executive officers and their affiliates are expected to vote any Ordinary Shares owned by them in favor of the Extension Proposal. On the Record Date, they beneficially owned and were entitled to
vote &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ordinary Shares, representing approximately &nbsp;&nbsp;&nbsp;&nbsp;% of the Company&#146;s issued and outstanding Ordinary Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company&#146;s Sponsor, directors and executive officers beneficially owned
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Public Shares in the aggregate as of the Record Date and may choose to purchase additional Public Shares in the open market and/or through negotiated
private transactions after the date of this proxy statement. In the event that such purchases do occur, the purchasers may seek to purchase shares from shareholders who would otherwise have voted against the Extension Proposal and/or elected to
redeem their shares. Any Public Shares so purchased will be voted in favor of the Extension Proposal. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Adjournment Proposal must be
approved by an ordinary resolution as a matter of Cayman Islands law, being the affirmative vote of a majority of the votes cast by the holders of the Ordinary Shares who are present in person (including virtually) or represented by proxy and
entitled to vote at the General Meeting. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Interests of the Company&#146;s Directors and Officers </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">When you consider the recommendation of the Board, you should keep in mind that the Company&#146;s executive officers and members of the Board
have interests that may be different from, or in addition to, your interests as a shareholder. These interests include, among other things: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the fact that James P. Benson will be the Sponsor&#146;s designee to the Combined Company Board upon the closing
of the Business Combination. As a director, in the future, Mr.&nbsp;Benson may receive any cash </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
fees, stock options or stock awards that the Combined Company Board determines to pay to its directors. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">If the Extension Proposal is not approved and we do not consummate an initial business combination by
October&nbsp;22, 2023, the 6,900,000 Insider Shares which were acquired for an aggregate purchase price of approximately $25,000 will be worthless (as the holders have waived liquidation rights with respect to such shares), as will the 14,040,000
Private Placement Warrants that were acquired simultaneously with the Company&#146;s IPO for an aggregate purchase price of $14,040,000. Such 6,900,000 Ordinary Shares had an aggregate market value of approximately
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; based on the closing price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; of the Ordinary Shares
on Nasdaq on the Record Date. Such Private Placement Warrants had an aggregate market value of approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; based on the closing price of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; of the public warrants on Nasdaq on the Record Date. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our Sponsor has agreed that, if we liquidate the Trust Account prior to the consummation of a business
combination, it will be liable to pay debts and obligations to target businesses or vendors or other entities that are owed money by us for services rendered or contracted for or products sold to us, but only to the extent necessary to ensure that
such debts or obligations do not reduce the amounts in the Trust Account and only if such parties have not executed a waiver of claims against the Trust Account. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">All rights specified in the Company&#146;s Existing Charter relating to the right of officers and directors to be
indemnified by the Company, and of the Company&#146;s officers and directors to be exculpated from monetary liability with respect to prior acts or omissions, will continue after a business combination. If the Extension Proposal is not approved and
the Company liquidates, the Company will not be able to perform its obligations to its officers and directors under those provisions. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our Sponsor, directors and officers have agreed to waive their rights to participate in any liquidation of our
Trust Account or other assets with respect to their Ordinary Shares and to vote their Ordinary Shares in favor of any dissolution and plan of distribution which we submit to a vote of Shareholders. There will be no distribution from the Trust
Account with respect to the Private Placement Warrants, which will expire worthless. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our officers and directors may loan funds to us and may be owed reimbursement for expenses incurred in connection
with certain activities on our behalf which would only be repaid if we complete an initial business combination. If the Extension Proposal is not approved and a business combination is not consummated, these <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses will not be repaid. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Additionally, if the Extension
Proposal is approved and the Company consummates an initial business combination, the officers and directors may have additional interests that would be described in the proxy statement for such transaction. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Board Recommendation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>THE BOARD
UNANIMOUSLY RECOMMENDS THAT YOU VOTE </B>&#147;<B>FOR</B>&#148;<B> THE EXTENSION PROPOSAL AND </B>&#147;<B>FOR</B>&#148;<B> THE ADJOURNMENT PROPOSAL. THE BOARD EXPRESSES NO OPINION AS TO WHETHER YOU SHOULD REDEEM YOUR PUBLIC SHARES.</B> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BENEFICIAL OWNERSHIP OF SECURITIES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following table sets forth as of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2023,
the number of Ordinary Shares beneficially owned by (i)&nbsp;each person who is known by us to be the beneficial owner of more than five percent of our issued and outstanding Ordinary Shares; (ii)&nbsp;each of our officers and directors; and
(iii)&nbsp;all of our officers and directors as a group. As of the Record Date, we had &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ordinary Shares issued and outstanding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Beneficial ownership is determined according to the rules of the SEC. Generally, a person has beneficial ownership of a security if the person
possesses sole or shared voting power of that security, including any securities that a person has the right to acquire beneficial ownership within 60 days. Unless otherwise indicated, we believe that all persons named in the table have sole voting
and investment power with respect to all Ordinary Shares owned by them. As per the definition of beneficial ownership above, the following table does not reflect record of beneficial ownership of any Ordinary Shares issuable upon exercise of
derivative securities that are not exercisable within 60 days of the Record Date. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="49%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ROWSPAN="2" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name of Beneficial Owner<SUP
STYLE="font-size:75%; vertical-align:top">(1)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Class&nbsp;B Ordinary Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Class&nbsp;A Ordinary Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Shares<BR>Beneficially<BR>Owned</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Approximate<BR>Percentage<BR>of Class<SUP STYLE="font-size:75%; vertical-align:top">(2)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Shares<BR>Beneficially<BR>Owned<SUP STYLE="font-size:75%; vertical-align:top">(3)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Approximate<BR>Percentage<BR>of Class</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ESGEN LLC (our sponsor)<SUP STYLE="font-size:75%; vertical-align:top">(4)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,619,077</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,240,000</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:75%; vertical-align:top">(5)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sea Otter Advisors LLC<SUP STYLE="font-size:75%; vertical-align:top">(6)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">165,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Andrea Bernatova</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Nader Daylami</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">James P. Benson</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael C. Mayon</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sanjay Bishnoi</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">138,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Larry L. Helm</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">138,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mark M. Jacobs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">138,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All officers and directors as a group (7&nbsp;individuals)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">414,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Unless otherwise noted, the business address of each of the following individuals or entities is 5956 Sherry
Lane, Suite 1400, Dallas, Texas 75225. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Based on 27,600,000 Class&nbsp;A ordinary shares (which includes Class&nbsp;A ordinary shares that are
underlying the units) as of December&nbsp;21, 2022. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Based on 6,900,000 Class&nbsp;B ordinary shares outstanding as of December&nbsp;21, 2022.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">ESGEN LLC is the record holder of the Class&nbsp;B ordinary shares reported herein. James P. Benson, Michael C.
Mayon and Andrea Bernatova are the managers of ESGEN LLC, and each of them disclaims beneficial ownership over any securities owned by ESGEN LLC in which he or she does not have any pecuniary interest. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents Private Placement Warrants to acquire Class&nbsp;A ordinary shares upon payment of $11.50 per share,
commencing 30 days after completion of our initial business combination. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Based on a Schedule 13D filed by Sea Otter Advisors LLC on March&nbsp;13, 2023. Sea Otter Advisors LLC serves
as the investment advisor to Sea Otter Trading LLC and has sole voting power and sole dispositive power over the ESGEN Class&nbsp;A ordinary shares held thereby. The address of the business office of Sea Otter Advisors LLC and Sea Otter Trading LLC
is 107 Grand St, 7th Floor, New York, New York 10013. The Sponsor, and our officers and directors are deemed to be our &#147;promoter&#148; as such term is defined under the federal securities laws. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Class&nbsp;B ordinary shares, Private Placement Warrants and any Class&nbsp;A ordinary shares issued upon conversion or exercise thereof
are each subject to transfer restrictions pursuant to <FONT STYLE="white-space:nowrap">lock-up</FONT> provisions in the Registration and Shareholder Rights Agreement, dated as of October&nbsp;22, 2021, by and among the Company, the Salient Client
Accounts, the Sponsor, Larry L. Helm, Mark M. Jacobs and Sanjay Bishnoi (the &#147;<B>Registration</B> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<B>and Shareholder Rights Agreement</B>&#148;) and the Warrant Agreement, dated October&nbsp;22, 2021, by and between the Company and Continental Stock Transfer&nbsp;&amp; Trust Company, as
warrant agent (the &#147;<B>Warrant Agreement</B>&#148;). Pursuant to the Registration and Shareholder Rights Agreement and the Warrant Agreement, our Sponsor, Larry L. Helm, Mark M. Jacobs, Sanjay Bishnoi and the Salient Client Accounts have agreed
not to transfer, assign or sell (i) any of their founder shares until the earliest of (A)&nbsp;one year after the completion of our initial business combination and (B)&nbsp;subsequent to our initial business combination, (x)&nbsp;if the closing
price of our Class&nbsp;A ordinary shares equals or exceeds $12.00 per share (as adjusted for share <FONT STYLE="white-space:nowrap">sub-divisions,</FONT> share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading
days within any <FONT STYLE="white-space:nowrap">30-trading</FONT> day period commencing at least 150 days after our initial business combination, or (y)&nbsp;the date on which we complete a liquidation, merger, share exchange, reorganization or
other similar transaction that results in all of our public shareholders having the right to exchange their ordinary shares for cash, securities or other property, and (ii)&nbsp;any of their Private Placement Warrants and Class&nbsp;A ordinary
shares issued upon conversion or exercise thereof until 30 days after the completion of our initial business combination. The foregoing restrictions are not applicable to transfers (a)&nbsp;to our officers or directors, any affiliates or family
members of any of our officers or directors, any members or partners of our sponsor or their affiliates, any affiliates of our sponsor, or any employees of such affiliates; (b)&nbsp;in the case of an individual, by gift to a member of one of the
individual&#146;s immediate family or to a trust, the beneficiary of which is a member of the individual&#146;s immediate family, an affiliate of such person or to a charitable organization; (c)&nbsp;in the case of an individual, by virtue of laws
of descent and distribution upon death of the individual; (d)&nbsp;in the case of an individual, pursuant to a qualified domestic relations order; (e)&nbsp;by private sales or transfers made in connection with the consummation of a business
combination at prices no greater than the price at which the Class&nbsp;B ordinary shares, Private Placement Warrants or Class&nbsp;A ordinary shares, as applicable, were originally purchased; (f)&nbsp;by virtue of our Sponsor&#146;s organizational
documents upon liquidation or dissolution of our Sponsor; (g)&nbsp;to the Company for no value for cancellation in connection with the consummation of our initial business combination; (h)&nbsp;in the event of our liquidation prior to the completion
of our initial business combination; or (i)&nbsp;in the event of our completion of a liquidation, merger, share exchange or other similar transaction which results in all of our public shareholders having the right to exchange their Class&nbsp;A
ordinary shares for cash, securities or other property subsequent to our completion of our initial business combination; provided, however, that in the case of clauses (a)&nbsp;through (f) these permitted transferees must enter into a written
agreement agreeing to be bound by these transfer restrictions and the other restrictions contained in the letter agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SHAREHOLDER PROPOSALS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the Extension Proposal is approved, the Extension Amendment is effective and an initial business combination is consummated, we expect that
the surviving company following such business combination will hold its 2024 annual meeting of Shareholders on a date to be determined by the surviving company. The date of such meeting and the date by which you may submit a proposal for inclusion
in the proxy statement will be included in a Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> or a Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the Extension Proposal is not approved and no initial business combination is consummated, there will be no further annual meetings of the
Company. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DELIVERY OF DOCUMENTS TO SHAREHOLDERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the rules of the SEC, the Company and its agents that deliver communications to its Shareholders are permitted to deliver to two
or more Shareholders sharing the same address a single copy of the Company&#146;s proxy statement. Upon written or oral request, the Company will deliver a separate copy of the proxy statement to any shareholder at a shared address who wishes to
receive separate copies of such documents in the future. Shareholders receiving multiple copies of such documents may likewise request that the Company deliver single copies of such documents in the future. Shareholders may notify the Company of
their requests by calling or writing the Company&#146;s proxy solicitor at the following: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Morrow Sodali LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">333 Ludlow Street, 5<SUP STYLE="font-size:75%; vertical-align:top">th</SUP> Floor </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">South Tower </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Stamford, CT 06902
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Toll-Free (800) <FONT STYLE="white-space:nowrap">662-5200</FONT> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Email: ESAC.info@investor.morrowsodali.com </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OTHER INFORMATION </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Company&#146;s 2022 Annual Report on Form <FONT STYLE="white-space:nowrap">10-K,</FONT> excluding exhibits, will be mailed without charge to any shareholder entitled to vote at the meeting, upon written request to Secretary, ESGEN Acquisition
Corporation, 5956 Sherry Lane, Suite 1400, Dallas, Texas 75225. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OTHER MATTERS TO BE PRESENTED AT THE GENERAL MEETING </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company did not have notice of any matter to be presented for action at the General Meeting, except as discussed in this proxy statement.
The persons authorized by the accompanying form of proxy will vote in their discretion as to any other matter that comes before the General Meeting. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>WHERE YOU CAN FIND MORE INFORMATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company files its reports, proxy statements and other information electronically with the SEC. You may access information on the Company
at the SEC website containing reports, proxy statements and other information at <I>http://www.sec.gov.</I> This proxy statement describes the material elements of relevant contracts, exhibits and other information attached as annexes to this proxy
statement. Information and statements contained in this proxy statement are qualified in all respects by reference to the copy of the relevant contract or other document included as an annex to this document. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This proxy statement contains important business and financial information about us that is not included in or delivered with this document.
You may obtain this additional information, or additional copies of this proxy statement, at no cost, and you may ask any questions you may have about the Extension Proposal by contacting the Company&#146;s proxy solicitor at the following: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Morrow Sodali LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">333 Ludlow
Street, 5<SUP STYLE="font-size:75%; vertical-align:top">th</SUP> Floor </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">South Tower </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Stamford, CT 06902 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Toll-Free
(800) <FONT STYLE="white-space:nowrap">662-5200</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Email: ESAC.info@investor.morrowsodali.com </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In order to receive timely delivery of the documents in advance of the General Meeting, you must make your request for information no later
than &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2023. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ANNEX A </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXTENSION AMENDMENT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDED AND RESTATED MEMORANDUM AND ARTICLES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OF ASSOCIATION OF </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ESGEN
ACQUISITION CORPORATION </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;RESOLVED, as a special resolution, that the proposed payment by the Company from the Company&#146;s working capital
account into the Trust Account of the lesser of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; or $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
for each Public Share that is outstanding following the exercise of redemption rights in connection with the Extension Proposal be approved and that the Amended and Restated Memorandum and Articles of Association of the Company be amended by the
deletion of the existing Article 165 in its entirety and the insertion of the following language in its place: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">165 (a) In the event that
either the Company does not consummate a Business Combination by twenty seven months after the closing of the IPO, subject to any extension in accordance with Article 165 (c), the Company shall: (i)&nbsp;cease all operations except for the purpose
of winding up; (ii)&nbsp;as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a <FONT STYLE="white-space:nowrap">per-Share</FONT> price, payable in cash, equal to the aggregate amount then
on deposit in the Trust Fund, including interest earned on the Trust Fund and not previously released to the Company to pay income taxes, if any (less up to $100,000 of interest to pay winding up and dissolution expenses), divided by the number of
Public Shares then in issue, which redemption will completely extinguish public Members&#146; rights as Members (including the right to receive further liquidation distributions, if any); and (iii)&nbsp;as promptly as reasonably possible following
such redemption, subject to the approval of the Company&#146;s remaining Members and the Directors, liquidate and dissolve, subject in the case of <FONT STYLE="white-space:nowrap">sub-articles</FONT> (ii)&nbsp;and (iii), to its obligations under
Cayman Islands law to provide for claims of creditors and in all cases subject to the other requirements of applicable law. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">165 (b) If any
amendment is made to Article 165(a) or 165(c) that would modify the substance or timing of the Company&#146;s obligation to provide holders of the Class&nbsp;A Shares the right to have their shares redeemed in connection with the Business
Combination or to redeem 100% of the Public Shares if the Company does not complete its initial Business Combination by January&nbsp;22, 2024 (the &#147;<B>Initial Business Combination Date</B>&#148;) or any subsequent Additional Extension Date (as
defined below) or with respect to any other provision relating to the rights of holders of the Class&nbsp;A Shares, each holder of Public Shares shall be provided with the opportunity to redeem their Public Shares upon the approval of any such
amendment at a <FONT STYLE="white-space:nowrap">per-Share</FONT> price, payable in cash, equal to the aggregate amount then on deposit in the Trust Fund, including interest earned on the Trust Fund and not previously released to the Company to pay
its income taxes, if any (less up to $100,000 of interest to pay winding up and dissolution expenses), divided by the number of Public Shares then in issue. Notwithstanding the foregoing, the Company shall not redeem Public Shares in connection with
such amendment that would cause the Company&#146;s net tangible assets to be less than US$5,000,001 (upon consummation of the Business Combination and after payment of underwriter fees and commissions) following such redemptions. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">165 (c) Notwithstanding this Article or any other provision of the Articles, in the event that the Company has not consummated an initial
Business Combination by the Initial Business Combination Date, the Company may, if requested by the Sponsor, without any approval of the Members, by resolution of the board of Directors and upon five days&#146; advance notice prior to the Initial
Business Combination Date, extend the deadline date of the initial Business Combination up to six times (with each such extension being upon five days&#146; advance notice) (each, an &#147;<B>Additional Extension Date</B>&#148;), each by one
additional month (for a total of up to six additional months to complete a Business Combination), provided that the Sponsor (or its affiliates or permitted designees) (the &#147;<B>Lender</B>&#148;) will deposit into the Trust Account: the lesser of
(a)&nbsp;US$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; or (b) $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; for each Public Share that is
then-outstanding, in exchange for one or more <FONT STYLE="white-space:nowrap">non-interest</FONT> bearing, unsecured promissory notes issued by the Company to the Lender. If the Company completes its initial Business Combination, it will, at the
option of the Lender, repay the amounts loaned under the promissory note or convert a portion or all of the amounts loaned under such promissory note(s) into warrants at a price of $1.00 per warrant, which warrants will be identical to the private
placement warrants issued to the Sponsor at the time of the IPO. If the Company does not complete a Business Combination by the deadline to consummate an initial Business Combination, such promissory notes will be repaid only from funds held outside
of the Trust Account.&#148; </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>ESGEN ACQUISITION CORPORATION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>5956 Sherry Lane, Suite 1400 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Dallas, Texas 75225 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>EXTRAORDINARY GENERAL MEETING </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2023 </B></P>
<P STYLE="margin-top:36pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>Important Notice Regarding the Internet Availability of Proxy </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>Materials for the Extraordinary General Meeting of Shareholders </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>to be held on &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2023
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>This notice of Extraordinary General Meeting </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>and the accompanying proxy statement are available at: </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>https://www.cstproxy.com/esgenspac/2023 </B></P>
<P STYLE="margin-top:120pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>


<IMG SRC="g555344g22y87.jpg" ALT="LOGO">
 FOLD HERE &#149; DO NOT SEPARATE &#149; INSERT IN ENVELOPE PROVIDED


<IMG SRC="g555344g22y87.jpg" ALT="LOGO">
 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>PROXY </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>ESGEN ACQUISITION CORPORATION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>THIS PROXY IS SOLICITED BY THE BOARD OF DIRECTORS FOR THE </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>EXTRAORDINARY GENERAL MEETING TO BE HELD
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2023 </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
undersigned, revoking any previous proxies relating to these shares, hereby acknowledges receipt of the Notice and Proxy Statement, dated
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2023 (the &#147;Proxy Statement&#148;), in connection with the Extraordinary General Meeting to be held at
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ET on &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2023 at the offices of Kirkland &amp; Ellis LLP,
609 Main Street, Houston, TX 77002, and virtually via tele-conference using the following dial-in information: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>US/CANADA Toll-Free
Dial-In Number: </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>INTERNATIONAL Toll-Free Dial-In Number: </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman"><B>Conference ID: </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The undersigned hereby
appoints &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; the attorney and proxy of the undersigned, with power of substitution, to vote all of the Class A and Class B ordinary shares, of <B>ESGEN
ACQUISITION CORPORATION</B>, a Cayman Islands exempted company (the &#147;Company&#148;) registered in the name provided, which the undersigned is entitled to attend and to vote (in person and virtually) at the Extraordinary General Meeting, and at
any adjournments and/or postponements thereof, with all the powers the undersigned would have if personally present. Without limiting the general authorization hereby given, said proxy is instructed to vote or act as follows on the proposal set
forth in the Proxy Statement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>THIS PROXY, WHEN EXECUTED, WILL BE VOTED IN THE MANNER DIRECTED HEREIN. IF NO DIRECTION IS MADE, THIS PROXY WILL BE VOTED
&#147;FOR&#148; PROPOSALS 1 AND 2 BELOW. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>NOTWITHSTANDING THE ORDER IN WHICH THE PROPOSALS ARE SET OUT HEREIN, THE COMPANY MAY PUT THE PROPOSALS TO
THE EXTRAORDINARY GENERAL MEETING IN SUCH ORDER AS IT MAY DETERMINE. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>THE BOARD UNANIMOUSLY RECOMMENDS THAT YOU VOTE &#147;FOR&#148; THE EXTENSION
PROPOSAL AND &#147;FOR&#148; THE ADJOURNMENT PROPOSAL. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PLEASE MARK, SIGN, DATE AND RETURN THE PROXY CARD PROMPTLY. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(to be marked, dated and signed on reverse side) </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><U STYLE="border-bottom:1pt double; padding-bottom:1pt">YOUR VOTE IS IMPORTANT. PLEASE
VOTE TODAY.</U> </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B>Vote by Internet &#150; QUICK


<IMG SRC="g555344star.jpg" ALT="LOGO">
 EASY </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B>IMMEDIATE &#150; 24 Hours a Day, 7 Days a Week or by Mail </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="43%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>ESGEN ACQUISITION</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>CORPORATION</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"><B>Your Internet vote authorizes the named proxies to vote your shares in the same manner as if you marked, signed and returned your proxy card. Votes submitted electronically over the Internet must be received by
11:59 p.m., Eastern Time, on &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2023.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">


<IMG SRC="g555344g08t76.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman"><B>INTERNET &#150;</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman"><B>www.cstproxyvote.com</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:11pt; font-family:Times New Roman">Use the Internet to vote your proxy.
Have your proxy card available when you access the above website. Follow the prompts to vote your shares.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">


<IMG SRC="g555344g97b44.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman"><B>Vote at the Meeting &#150;</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman">If you
plan to attend the virtual online extraordinary general meeting, you will need your 12 digit control number to vote electronically at the extraordinary general meeting. To attend the extraordinary general meeting, visit:</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:11pt; font-family:Times New Roman"><B><U>https://www.cstproxy.com/esgenspac/2023</U></B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">


<IMG SRC="g555344g56e92.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B>MAIL</B> &#150; Mark, sign and date your proxy card and return it in the postage-paid envelope provided.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>PLEASE DO NOT RETURN THE PROXY
CARD</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>IF YOU ARE VOTING ELECTRONICALLY.</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"><B>


<IMG SRC="g555344g22y87.jpg" ALT="LOGO">
 FOLD HERE &#149; DO NOT SEPARATE &#149; INSERT IN ENVELOPE PROVIDED


<IMG SRC="g555344g22y87.jpg" ALT="LOGO">
</B></TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:5pt" ALIGN="center">


<TR>

<TD WIDTH="90%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:5pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>PROXY</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">Please&nbsp;mark</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;&nbsp;</TD>
<TD ROWSPAN="2" NOWRAP VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt">&nbsp;</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD ROWSPAN="2" NOWRAP VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt" ALIGN="right">


<IMG SRC="g555344g36a01.jpg" ALT="LOGO">
</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD ROWSPAN="2" NOWRAP VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt">&nbsp;</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:5pt">
<TD VALIGN="top"><FONT STYLE="font-size:12pt"><B>ESGEN ACQUISITION CORPORATION &#151; THE BOARD OF DIRECTORS RECOMMENDS A VOTE &#147;FOR&#148; PROPOSALS 1 AND 2.</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">your&nbsp;votes<BR> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:5pt; font-family:Times New Roman" ALIGN="center">like this</P></TD></TR>
</TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV STYLE="position:relative;float:left; width:48%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="10%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="10%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman"><B>1.</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt"><B>Proposal 1. &#151; Extension Proposal</B> &#151; by special resolution to amend the Company&#146;s amended and restated memorandum and articles of association to: (i) extend from October 22, 2023 to
January 22, 2024 (the</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="font-size:6pt">FOR </FONT></B>&#9744;<B></B><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="font-size:6pt">AGAINST </FONT></B>&#9744;<B></B><B></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="font-size:6pt">ABSTAIN </FONT></B>&#9744;<B></B><B></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="7">&#147;New Extended Date&#148;), the date (the &#147;Termination Date&#148;) by which, if the Company has not consummated a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or
similar business combination involving one or more businesses or entities, the Company must: (a) cease all operations except for the purpose of winding up; (b) as promptly as reasonably possible but not more than ten business days thereafter, redeem
the shares sold in the Company&#146;s initial public offering (the &#147;Public Shares&#148;) (in a redemption that will completely extinguish the rights of the owners of the Public Shares as shareholders (including the right to receive further
liquidation distributions, if any)) at a per-share price, payable in cash, equal to (1) the aggregate amount then on deposit in the trust account located in the United States with Continental Stock Transfer &amp; Trust Company acting as trustee
(&#147;Trust Account&#148;), including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its income taxes, if any, less up to $100,000 of interest to pay winding up and dissolution expenses (net
of any taxes payable), divided by (2) the number of the then-outstanding Public Shares; and (c) as promptly as reasonably possible following such redemption, subject to the approval of the Company&#146;s remaining shareholders and the Board,
liquidate and dissolve, subject in the case of clauses (b) and (c) to the Company&#146;s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law, and (ii) in the event that the Company has
not consummated an initial business combination by the New Extended Date, to allow the Company, by resolution of the board of directors of the Company and, without any approval of the Company&#146;s shareholders, upon five days&#146; advance notice
prior to the New Extended Date to extend the Termination Date up to six times (with each such extension being upon five days&#146; advance notice), each by one additional month (for a total of up to six additional months to complete a business
combination) (each, an &#147;Additional Extension Date&#148;), provided that the Company&#146;s sponsor, ESGEN LLC (the &#147;Sponsor&#148;) or the Sponsor&#146;s affiliates or permitted designees (the &#147;Lenders&#148; and each a
&#147;Lender&#148;) will deposit into the Trust Account for each Additional Extension Date the lesser of (a) US$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; or (b)
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; for each Public Share that is then-outstanding, in exchange for one or more</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR></TABLE>
</DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:49%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="10%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="10%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="9"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">non-interest bearing, unsecured promissory notes issued by the Company to the Lender. If the Company completes its initial
business combination, it will, at the option of the Lender, repay the amounts loaned under the promissory note(s) or convert a portion or all of the amounts loaned under such promissory note(s) into warrants at a price of $1.00 per warrant, which
warrants will be identical to the private placement warrants, each exercisable to purchase one Class A ordinary share, par value $0.0001 at $11.50 per share, subject to adjustment, at a price of $1.00 per warrant issued to the Sponsor at the time of
the Company&#146;s initial public offering, If the Company does not complete a business combination by the deadline to consummate an initial business combination, such promissory notes will be repaid only from funds held outside of the Trust
Account.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman"><B>2.</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"><FONT STYLE="font-size:8pt"><B>Proposal 2. &#151; The Adjournment Proposal</B> &#151; by ordinary resolution to approve the adjournment of the General Meeting by the chairman thereof to a later date, if necessary,
under certain circumstances, to</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:6pt; font-family:Times New Roman" ALIGN="center"><B>FOR</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:6pt; font-family:Times New Roman" ALIGN="center"><B>AGAINST</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:6pt; font-family:Times New Roman" ALIGN="center"><B>ABSTAIN</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">&#9744;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="9"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">solicit additional proxies for the purpose of approving the Extension Proposal, to amend the Extension Proposal, or to allow
reasonable additional time for the filing or mailing of any supplemental or amended disclosure that the Company has determined in good faith after consultation with outside legal counsel is required under applicable law and for such supplemental or
amended disclosure to be disseminated and reviewed by the Company&#146;s shareholders prior to the General Meeting; provided that the General Meeting is reconvened as promptly as practical thereafter. The Adjournment Proposal will only be presented
at the General Meeting if there are not sufficient tabulated votes to approve the Extension Proposal.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>The Shares represented by this proxy, when properly executed, will be voted in the manner directed herein by the undersigned shareholder(s). If no direction
is made, this proxy will be voted FOR Proposals 1 and 2. If any other matters properly come before the Extraordinary General Meeting, unless such authority is withheld on this proxy card, the Proxies will vote on such matters in their
discretion.</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center">CONTROL NUMBER</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> </div><div style="clear:both; height:0pt; font-size:0pt">&nbsp;</div>
 <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman"><B>Signature
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> Signature, if held jointly
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>
Date<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>2023. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman">Note: When Shares are held by joint tenants, both should sign. When signing as attorney, executor, administrator, trustee or guardian, please give full title as
such. If a corporation, please sign in full corporate name by the president or another authorized officer. If a partnership, please sign in partnership name by an authorized person. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g555344g08t76.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g555344g08t76.jpg
M_]C_X01R17AI9@  34T *@    @ !P$2  ,    !  $   $:  4    !
M8@$;  4    !    :@$H  ,    !  (   $Q  (    >    <@$R  (    4
M    D(=I  0    !    I    -  +<;    G$  MQL   "<0061O8F4@4&AO
M=&]S:&]P($-3-B H5VEN9&]W<RD ,C R,SHP.3HQ,B R,SHQ,CHU-P   Z !
M  ,    !__\  * "  0    !    '* #  0    !    &0         & 0,
M P    $ !@   1H !0    $   $> 1L !0    $   $F 2@  P    $  @
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M 0,1 ?_=  0  O_$ 3\   $% 0$! 0$!          ,  0($!08'" D*"P$
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MP_K/=1C5DBJIAN8UH)W?S==^QO\ 97'_ %M?]9OJUU&O /UARLTOJ%ILKOM
M$N?7Z9_3/]WZ->^+Y<S_ .G9/_&O_P"J*2GU#IGU'^MW4<#'S:?K9?%]3+2P
M67.+=[6V>FXMO^DW<B_^-/\ 6#[1^T/^<EO[2^A]IBS?LC9M^T>OZWT?:C_X
MD?\ D3J'_AH?^>V+T=)3_]G_[0Q24&AO=&]S:&]P(#,N,  X0DE-! 0
M  \< 5H  QLE1QP"   "MT8 .$))300E       0*:A?N?6P34\A!&*^6'_X
M#3A"24T$.@      Y0   !     !       +<')I;G1/=71P=70    %
M %!S=%-B;V]L 0    !);G1E96YU;0    !);G1E     $-L<FT    /<')I
M;G13:7AT965N0FET8F]O;      +<')I;G1E<DYA;65415A4     0
M#W!R:6YT4')O;V93971U<$]B:F,    , %  <@!O &\ 9@ @ %, 90!T '4
M<       "G!R;V]F4V5T=7     !     $)L=&YE;G5M    #&)U:6QT:6Y0
M<F]O9@    EP<F]O9D--64L .$))300[      (M    $     $      !)P
M<FEN=$]U='!U=$]P=&EO;G,    7     $-P=&YB;V]L      !#;&)R8F]O
M;       4F=S36)O;VP      $-R;D-B;V]L      !#;G1#8F]O;
M3&)L<V)O;VP      $YG='9B;V]L      !%;6Q$8F]O;       26YT<F)O
M;VP      $)C:V=/8FIC     0       %)'0D,    #     %)D("!D;W5B
M0&_@            1W)N(&1O=6) ;^            !";" @9&]U8D!OX
M         $)R9%15;G1&(U)L=                $)L9"!5;G1&(U)L=
M             %)S;'15;G1&(U!X;$!RP           "G9E8W1O<D1A=&%B
M;V]L 0    !09U!S96YU;0    !09U!S     %!G4$,     3&5F=%5N=$8C
M4FQT                5&]P(%5N=$8C4FQT                4V-L(%5N
M=$8C4')C0%D            08W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R
M;W!296-T0F]T=&]M;&]N9P         ,8W)O<%)E8W1,969T;&]N9P
M   -8W)O<%)E8W12:6=H=&QO;F<         "V-R;W!296-T5&]P;&]N9P
M    .$))30/M       0 2P    !  (!+     $  CA"24T$)@      #@
M           _@   .$))300-       $    >#A"24T$&0      !    !XX
M0DE- _,       D           $ .$))32<0       *  $          CA"
M24T#]0      2  O9F8  0!L9F8 !@       0 O9F8  0"AF9H !@
M 0 R     0!:    !@       0 U     0 M    !@       3A"24T#^
M    <   _____________________________P/H     /______________
M______________\#Z     #_____________________________ ^@
M_____________________________P/H   X0DE-! @      !     !   "
M0    D      .$))300>       $     #A"24T$&@     #0P    8
M         !D    <    !P!2 &D 9 !E '( +0 Q     0
M           !               <    &0                     !
M                     !     !        ;G5L;     (    &8F]U;F1S
M3V)J8P    $       !28W0Q    !     !4;W @;&]N9P          3&5F
M=&QO;F<          $)T;VUL;VYG    &0    !29VAT;&]N9P   !P    &
M<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E    $@    =S;&EC
M94E$;&]N9P         '9W)O=7!)1&QO;F<         !F]R:6=I;F5N=6T
M   ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960     5'EP965N=6T
M   *15-L:6-E5'EP90    !);6<@    !F)O=6YD<T]B:F,    !
M4F-T,0    0     5&]P(&QO;F<          $QE9G1L;VYG          !"
M=&]M;&]N9P   !D     4F=H=&QO;F<    <     W5R;%1%6%0    !
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M3001       ! 0 X0DE-!!0       0    ".$))300,      -8     0
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M(0      50    $!    #P!! &0 ;P!B &4 ( !0 &@ ;P!T &\ <P!H &\
M<    !, 00!D &\ 8@!E "  4 !H &\ = !O ', : !O '  ( !# %, -@
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M :(    & @,!              <(!@4$"0,* @$ "P$   8# 0$!
M    !@4$ P<"" $)  H+$  " 0,$ 0,# @,# P(&"74! @,$$042!B$'$R(
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$7NO_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g555344g22y87.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g555344g22y87.jpg
M_]C_X  02D9)1@ !  $ 8 !@  #__@ ?3$5!1"!496-H;F]L;V=I97,@26YC
M+B!6,2XP,0#_VP"$  @&!@<&!0@'!P<*"0@*#18.#0P,#1L3%! 6(!PB(1\<
M'QXC*#,K(R8P)AX?+#TM,#4V.3HY(BL_0SXX0S,X.3<!"0H*#0L-&@X.&C<D
M'R0W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W
M-S<W-S<W-__$ :(   $% 0$! 0$!           ! @,$!08'" D*"P$  P$!
M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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'_6*?5V/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g555344g36a01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g555344g36a01.jpg
M_]C_X03;17AI9@  34T *@    @ !P$2  ,    !  $   $:  4    !
M8@$;  4    !    :@$H  ,    !  (   $Q  (    >    <@$R  (    4
M    D(=I  0    !    I    -  +<;    G$  MQL   "<0061O8F4@4&AO
M=&]S:&]P($-3-B H5VEN9&]W<RD ,C R,SHP.3HQ,B R,SHQ,CHS,P   Z !
M  ,    !__\  * "  0    !    (: #  0    !    '@         & 0,
M P    $ !@   1H !0    $   $> 1L !0    $   $F 2@  P    $  @
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M 0,1 ?_=  0  __$ 3\   $% 0$! 0$!          ,  0($!08'" D*"P$
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M;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B;V]L
M  !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L      !%;6Q$
M8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0       %)'0D,
M   #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M  !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
M $)L9"!5;G1&(U)L=                %)S;'15;G1&(U!X;$!RP
M    "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0    !09U!S     %!G
M4$,     3&5F=%5N=$8C4FQT                5&]P(%5N=$8C4FQT
M            4V-L(%5N=$8C4')C0%D            08W)O<%=H96Y0<FEN
M=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P         ,8W)O<%)E
M8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<         "V-R
M;W!296-T5&]P;&]N9P      .$))30/M       0 2P    !  (!+     $
M CA"24T$)@      #@             _@   .$))300-       $    >#A"
M24T$&0      !    !XX0DE- _,       D           $ .$))32<0
M   *  $          CA"24T#]0      2  O9F8  0!L9F8 !@       0 O
M9F8  0"AF9H !@       0 R     0!:    !@       0 U     0 M
M!@       3A"24T#^       <   _____________________________P/H
M     /____________________________\#Z     #_________________
M____________ ^@     _____________________________P/H   X0DE-
M! @      !     !   "0    D      .$))300>       $     #A"24T$
M&@     #30    8              !X    A    # !2 &D 9 !E '( +0 Q
M "  8P!O '  >0    $                          0
M(0   !X                      0                         0
M 0       &YU;&P    "    !F)O=6YD<T]B:F,    !        4F-T,0
M  0     5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M;&]N
M9P   !X     4F=H=&QO;F<    A    !G-L:6-E<U9L3',    !3V)J8P
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M;VYG    (0    -U<FQ415A4     0       &YU;&Q415A4     0
M $US9V5415A4     0      !F%L=%1A9U1%6%0    !       .8V5L;%1E
M>'1)<TA434QB;V]L 0    AC96QL5&5X=%1%6%0    !       ):&]R>D%L
M:6=N96YU;0    ]%4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV97)T
M06QI9VYE;G5M    #T53;&EC959E<G1!;&EG;@    =D969A=6QT    "V)G
M0V]L;W)4>7!E96YU;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE
M"71O<$]U='-E=&QO;F<         "FQE9G1/=71S971L;VYG          QB
M;W1T;VU/=71S971L;VYG          MR:6=H=$]U='-E=&QO;F<      #A"
M24T$*       #     (_\        #A"24T$$0       0$ .$))3004
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MY?569G:&EJ:VQM;F]C='5V=WAY>GM\?7Y_<1  (" 0($! ,$!08'!P8%-0$
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M_"X]GII*=_J61]2^E95.'GUXM.3DQZ%/HASW2[TV[6UUO^D_VK0NZ)T85/\
MU''^B?\ !,\/ZJX;_%]T^_ZQ=:R_KEU9S;+66&K%I&K6/#8<X,=.QE%;O3Q]
MW[]ER]&N_F7_ -4_D24^0Z^)^\I))))?_]#T;H/_ "+A?\2S\BX+ZR79OUV^
MM=/U=PM]?2.GO+\O(VD,<YAVW6-<1M=L_HV-_P *^RY=CT7-RF=(PVMP+[ V
MIH#VNH@P/I-WY#'^[^6Q7?M^9_Y6Y'^?C_\ O2DI\]KKR?\ %[]<-K&66?5W
MJD20'/%8'YSHW.]3#<[_ *[BV?Z1>F6D&AY!D%I((^"J_;\S_P K<C_/Q_\
MWI4;L_,])_\ DW(^B?S\?P_\,I*?+DDH/E]Y_P#(I))?_]D .$))300A
M  !5     0$    / $$ 9 !O &( 90 @ %  : !O '0 ;P!S &@ ;P!P
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M P,# P,# P,# P,# P/_P  1"  > "$# 1$  A$! Q$!_]T !  %_\0!H@
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M;_V1?\7O_$(]??\ O/4?OW6V^)OMZU)/YCV\NY_Y]/\ -6ZS_EF]$1;YVO\
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* -8??NE/Y=?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g555344g56e92.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g555344g56e92.jpg
M_]C_X01 17AI9@  34T *@    @ !P$2  ,    !  $   $:  4    !
M8@$;  4    !    :@$H  ,    !  (   $Q  (    >    <@$R  (    4
M    D(=I  0    !    I    -  +<;    G$  MQL   "<0061O8F4@4&AO
M=&]S:&]P($-3-B H5VEN9&]W<RD ,C R,SHP.3HQ,B R,SHQ,3HU-P   Z !
M  ,    !__\  * "  0    !    %J #  0    !    $0         & 0,
M P    $ !@   1H !0    $   $> 1L !0    $   $F 2@  P    $  @
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M 0,1 ?_=  0  O_$ 3\   $% 0$! 0$!          ,  0($!08'" D*"P$
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M=%!R;V]F4V5T=7!/8FIC    # !0 '( ;P!O &8 ( !3 &4 = !U '
M  IP<F]O9E-E='5P     0    !";'1N96YU;0    QB=6EL=&EN4')O;V8
M   )<')O;V9#35E+ #A"24T$.P     "+0   !     !       2<')I;G1/
M=71P=71/<'1I;VYS    %P    !#<'1N8F]O;       0VQB<F)O;VP
M %)G<TUB;V]L      !#<FY#8F]O;       0VYT0V)O;VP      $QB;'-B
M;V]L      !.9W1V8F]O;       16UL1&)O;VP      $EN=')B;V]L
M  !"8VMG3V)J8P    $       !21T)#     P    !29" @9&]U8D!OX
M         $=R;B!D;W5B0&_@            0FP@(&1O=6) ;^
M  !"<F1456YT1B-2;'0               !";&0@56YT1B-2;'0
M      !2<VQT56YT1B-0>&Q <L            IV96-T;W)$871A8F]O; $
M    4&=0<V5N=6T     4&=0<P    !09U!#     $QE9G15;G1&(U)L=
M             %1O<"!5;G1&(U)L=                %-C;"!5;G1&(U!R
M8T!9            $&-R;W!7:&5N4')I;G1I;F=B;V]L      YC<F]P4F5C
M=$)O='1O;6QO;F<         #&-R;W!296-T3&5F=&QO;F<         #6-R
M;W!296-T4FEG:'1L;VYG          MC<F]P4F5C=%1O<&QO;F<      #A"
M24T#[0      $ $L     0 " 2P    !  (X0DE-!"8       X
M    /X   #A"24T$#0      !    '@X0DE-!!D       0    >.$))30/S
M       )           ! #A"24TG$       "@ !          (X0DE- _4
M     $@ +V9F  $ ;&9F  8       $ +V9F  $ H9F:  8       $ ,@
M  $ 6@    8       $ -0    $ +0    8       $X0DE- _@      '
M /____________________________\#Z     #_____________________
M________ ^@     _____________________________P/H     /______
M______________________\#Z   .$))300(       0     0   D    )
M     #A"24T$'@      !      X0DE-!!H      TT    &
M   1    %@    P 4@!I &0 90!R "T ,0 @ &, ;P!P 'D    !
M                  $              !8    1
M  $                         $     $       !N=6QL     @    9B
M;W5N9'-/8FIC     0       %)C=#$    $     %1O<"!L;VYG
M  !,969T;&]N9P          0G1O;6QO;F<    1     %)G:'1L;VYG
M%@    9S;&EC97-6;$QS     4]B:F,    !       %<VQI8V4    2
M!W-L:6-E241L;VYG          =G<F]U<$E$;&]N9P         &;W)I9VEN
M96YU;0    Q%4VQI8V5/<FEG:6X    -875T;T=E;F5R871E9     !4>7!E
M96YU;0    I%4VQI8V54>7!E     $EM9R     &8F]U;F1S3V)J8P    $
M      !28W0Q    !     !4;W @;&]N9P          3&5F=&QO;F<
M     $)T;VUL;VYG    $0    !29VAT;&]N9P   !8    #=7)L5$585
M  $       !N=6QL5$585     $       !-<V=E5$585     $       9A
M;'1486=415A4     0      #F-E;&Q497AT27-(5$U,8F]O; $    (8V5L
M;%1E>'1415A4     0      "6AO<GI!;&EG;F5N=6T    /15-L:6-E2&]R
M>D%L:6=N    !V1E9F%U;'0    )=F5R=$%L:6=N96YU;0    ]%4VQI8V56
M97)T06QI9VX    '9&5F875L=     MB9T-O;&]R5'EP965N=6T    115-L
M:6-E0D=#;VQO<E1Y<&4     3F]N90    ET;W!/=71S971L;VYG
M  IL969T3W5T<V5T;&]N9P         ,8F]T=&]M3W5T<V5T;&]N9P
M   +<FEG:'1/=71S971L;VYG       X0DE-!"@       P    "/_
M   X0DE-!!$       $! #A"24T$%       !     (X0DE-! P      R8
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M!0$! 0$! 0         #  $"! 4&!P@)"@L!  $% 0$! 0$!          $
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M(0      50    $!    #P!! &0 ;P!B &4 ( !0 &@ ;P!T &\ <P!H &\
M<    !, 00!D &\ 8@!E "  4 !H &\ = !O ', : !O '  ( !# %, -@
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M :(    & @,!              <(!@4$"0,* @$ "P$   8# 0$!
M    !@4$ P<"" $)  H+$  " 0,$ 0,# @,# P(&"74! @,$$042!B$'$R(
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.._P#WR^9]^]>MC@W7_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g555344g97b44.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g555344g97b44.jpg
M_]C_X1&-17AI9@  34T *@    @ !P$2  ,    !  $   $:  4    !
M8@$;  4    !    :@$H  ,    !  (   $Q  (    >    <@$R  (    4
M    D(=I  0    !    I    -  +<;    G$  MQL   "<0061O8F4@4&AO
M=&]S:&]P($-3-B H5VEN9&]W<RD ,C R,SHP.3HQ,B R,SHQ,3HR-P   Z !
M  ,    !__\  * "  0    !    *: #  0    !    &0         & 0,
M P    $ !@   1H !0    $   $> 1L !0    $   $F 2@  P    $  @
M @$ !     $   $N @( !     $  !!7         $@    !    2     '_
MV/_B#%A)0T-?4%)/1DE,10 ! 0  #$A,:6YO A   &UN=')21T(@6%E:( ?.
M  ( "0 & #$  &%C<W!-4T94     $E%0R!S4D="                  #V
MU@ !     -,M2% @(
M                    $6-P<G0   %0    ,V1E<V,   &$    ;'=T<'0
M  'P    %&)K<'0   ($    %')865H   (8    %&=865H   (L    %&)8
M65H   )     %&1M;F0   )4    <&1M9&0   +$    B'9U960   -,
MAG9I97<   /4    )&QU;6D   /X    %&UE87,   0,    )'1E8V@   0P
M    #')44D,   0\   (#&=44D,   0\   (#&)44D,   0\   (#'1E>'0
M    0V]P>7)I9VAT("AC*2 Q.3DX($AE=VQE='0M4&%C:V%R9"!#;VUP86YY
M  !D97-C         !)S4D="($E%0S8Q.38V+3(N,0              $G-2
M1T(@245#-C$Y-C8M,BXQ
M                          !865H@        \U$  0    $6S%A96B
M                    6%E:(        &^B   X]0   Y!865H@
M8ID  +>%   8VEA96B         DH   #X0  +;/9&5S8P         6245#
M(&AT=' Z+R]W=W<N:65C+F-H               6245#(&AT=' Z+R]W=W<N
M:65C+F-H
M         &1E<V,         +DE%0R V,3DV-BTR+C$@1&5F875L="!21T(@
M8V]L;W5R('-P86-E("T@<U)'0@              +DE%0R V,3DV-BTR+C$@
M1&5F875L="!21T(@8V]L;W5R('-P86-E("T@<U)'0@
M          !D97-C         "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I
M;VX@:6X@245#-C$Y-C8M,BXQ               L4F5F97)E;F-E(%9I97=I
M;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0
M            =FEE=P      $Z3^ !1?+@ 0SQ0  ^W,  03"P #7)X    !
M6%E:(       3 E6 %    !7'^=M96%S          $
M       "CP    )S:6<@     $-25"!C=7)V        !      %  H #P 4
M !D '@ C "@ +0 R #< .P!  $4 2@!/ %0 60!> &, : !M '( =P!\ ($
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M# P,# P1$0P,# P,#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P,_\
M$0@ &0 I P$B  (1 0,1 ?_=  0  __$ 3\   $% 0$! 0$!          ,
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M24T$)0      $"FH7[GUL$U/(01BOEA_^ TX0DE-!#H      .4    0
M 0      "W!R:6YT3W5T<'5T    !0    !0<W138F]O; $     26YT965N
M=6T     26YT90    !#;')M    #W!R:6YT4VEX=&5E;D)I=&)O;VP
M"W!R:6YT97).86UE5$585     $       ]P<FEN=%!R;V]F4V5T=7!/8FIC
M    # !0 '( ;P!O &8 ( !3 &4 = !U '        IP<F]O9E-E='5P
M 0    !";'1N96YU;0    QB=6EL=&EN4')O;V8    )<')O;V9#35E+ #A"
M24T$.P     "+0   !     !       2<')I;G1/=71P=71/<'1I;VYS
M%P    !#<'1N8F]O;       0VQB<F)O;VP      %)G<TUB;V]L      !#
M<FY#8F]O;       0VYT0V)O;VP      $QB;'-B;V]L      !.9W1V8F]O
M;       16UL1&)O;VP      $EN=')B;V]L      !"8VMG3V)J8P    $
M      !21T)#     P    !29" @9&]U8D!OX            $=R;B!D;W5B
M0&_@            0FP@(&1O=6) ;^            !"<F1456YT1B-2;'0
M              !";&0@56YT1B-2;'0               !2<VQT56YT1B-0
M>&Q <L            IV96-T;W)$871A8F]O; $     4&=0<V5N=6T
M4&=0<P    !09U!#     $QE9G15;G1&(U)L=                %1O<"!5
M;G1&(U)L=                %-C;"!5;G1&(U!R8T!9            $&-R
M;W!7:&5N4')I;G1I;F=B;V]L      YC<F]P4F5C=$)O='1O;6QO;F<
M    #&-R;W!296-T3&5F=&QO;F<         #6-R;W!296-T4FEG:'1L;VYG
M          MC<F]P4F5C=%1O<&QO;F<      #A"24T#[0      $ $L
M 0 " 2P    !  (X0DE-!"8       X             /X   #A"24T$#0
M    !    '@X0DE-!!D       0    >.$))30/S       )           !
M #A"24TG$       "@ !          (X0DE- _4      $@ +V9F  $ ;&9F
M  8       $ +V9F  $ H9F:  8       $ ,@    $ 6@    8       $
M-0    $ +0    8       $X0DE- _@      '   /__________________
M__________\#Z     #_____________________________ ^@     ____
M_________________________P/H     /__________________________
M__\#Z   .$))300(       0     0   D    )      #A"24T$'@
M!      X0DE-!!H      U$    &               9    *0    X 4@!I
M &0 90!R "T ,0 @ &, ;P!P 'D (  R     0
M   !               I    &0                     !
M             !     !        ;G5L;     (    &8F]U;F1S3V)J8P
M  $       !28W0Q    !     !4;W @;&]N9P          3&5F=&QO;F<
M         $)T;VUL;VYG    &0    !29VAT;&]N9P   "D    &<VQI8V5S
M5FQ,<P    %/8FIC     0      !7-L:6-E    $@    =S;&EC94E$;&]N
M9P         '9W)O=7!)1&QO;F<         !F]R:6=I;F5N=6T    ,15-L
M:6-E3W)I9VEN    #6%U=&]'96YE<F%T960     5'EP965N=6T    *15-L
M:6-E5'EP90    !);6<@    !F)O=6YD<T]B:F,    !        4F-T,0
M  0     5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M;&]N
M9P   !D     4F=H=&QO;F<    I     W5R;%1%6%0    !        ;G5L
M;%1%6%0    !        37-G951%6%0    !       &86QT5&%G5$585
M  $       YC96QL5&5X=$ES2%1-3&)O;VP!    "&-E;&Q497AT5$585
M  $       EH;W)Z06QI9VYE;G5M    #T53;&EC94AO<GI!;&EG;@    =D
M969A=6QT    "79E<G1!;&EG;F5N=6T    /15-L:6-E5F5R=$%L:6=N
M!V1E9F%U;'0    +8F=#;VQO<E1Y<&5E;G5M    $453;&EC94)'0V]L;W)4
M>7!E     $YO;F4    )=&]P3W5T<V5T;&]N9P         *;&5F=$]U='-E
M=&QO;F<         #&)O='1O;4]U='-E=&QO;F<         "W)I9VAT3W5T
M<V5T;&]N9P      .$))300H       ,     C_P        .$))3001
M   ! 0 X0DE-!!0       0    ".$))300,     !!S     0   "D    9
M    ?   #!P  !!7 !@  ?_8_^(,6$E#0U]04D]&24Q%  $!   ,2$QI;F\"
M$   ;6YT<E)'0B!865H@!\X  @ )  8 ,0  86-S<$U31E0     245#('-2
M1T(                  /;6  $     TRU(4" @
M                                           18W!R=    5     S
M9&5S8P   80   !L=W1P=    ?     48FMP=    @0    4<EA96@   A@
M   49UA96@   BP    48EA96@   D     49&UN9    E0   !P9&UD9
M L0   "(=G5E9    TP   "&=FEE=P   ]0    D;'5M:0   _@    4;65A
M<P  ! P    D=&5C:   !#     ,<E120P  !#P   @,9U120P  !#P   @,
M8E120P  !#P   @,=&5X=     !#;W!Y<FEG:'0@*&,I(#$Y.3@@2&5W;&5T
M="U086-K87)D($-O;7!A;GD  &1E<V,         $G-21T(@245#-C$Y-C8M
M,BXQ               2<U)'0B!)14,V,3DV-BTR+C$
M                                                 %A96B
M  #S40 !     1;,6%E:(                     !865H@        ;Z(
M #CU   #D%A96B        !BF0  MX4  !C:6%E:(        "2@   /A
MML]D97-C         !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M                                9&5S8P         N245#(#8Q.38V
M+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@+2!S4D="
M   N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@+2!S
M4D="                             &1E<V,         +%)E9F5R96YC
M92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$
M "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6X@245#-C$Y-C8M,BXQ
M                                  !V:65W       3I/X %%\N !#/
M%  #[<P !!,+  -<G@    %865H@      !,"58 4    %<?YVUE87,
M     0                        */     G-I9R      0U)4(&-U<G8
M       $      4 "@ / !0 &0 > ", *  M #( -P [ $  10!* $\ 5 !9
M %X 8P!H &T <@!W 'P @0"& (L D "5 )H GP"D *D K@"R +< O #! ,8
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M# P,# P,# P,# P,# S_P  1"  9 "D# 2(  A$! Q$!_]T !  #_\0!/P
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MUV(R>E8?3NGN=?TUF15A"W)K8",C])=ZUMU5=>YNS]%[UF]1_P"4<K_CK/\
MJBJ&9_1G_+\J2GN<;/\ K'BLPV5]-81@8]N)3NZEB&67;=[K/=[K6^G7L67;
M]>']%S:,?,Z<7VX.$>G[&Y=;]U%FQ_NRL2M^V_V5?I*GKAEIX/\ 1Q\3^5)3
MV/1/\:_3,3J6;FY6!?6S)IQ:*JJGBXM;C"YNZRZ_T7O<_P!=>E_\X^F^-G^8
M5X8S^<9_6'Y5[XDI_]D .$))300A      !5     0$    / $$ 9 !O &(
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MJ+C(V.CX.4E9:7F)F:FYR=GI^2HZ2EIJ>HJ:JKK*VNKZ_]H # ,!  (1 Q$
M/P"_#^==\==I_,OY#?RE?B#V=N[M#:G4?>'R+^2+;];J7>U5L3==9)UO\/\
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CLK_[G2^_=>Z&_!_\7W ?]K_!_P#NUH_?NO=?7-]^Z]U__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g555344star.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g555344star.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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L7Q2K8#,%5FVZGUO%X["87$UN=OF_?8?%UZ,Z=_9.#IKD7L*'L_JBN0Z3_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
